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ABSTRACT 
The use of donated gametes has made parenthood possible for those women 
and men who are unable to conceive with their own. The number of 
treatments using donor gametes are constantly increasing worldwide. 
Although thousands of donor-conceived babies are born every year, parental 
psychological health has scarcely been addressed and most of the existing 
studies have concentrated on the parent-child relationship. One of the most 
important questions in gamete donation is whether the child should be 
informed about his/her genetic background. 
The purpose of this study was to explore parental psychological well-being 
during pregnancy and early parenthood after successful oocyte donation 
(OD) treatment. Special interest was focused on OD mothers’ fear of 
childbirth and delivery experience. Another aim was to examine attitudes 
and disclosure decisions of parents conceived with sperm or oocyte donation. 
A prospective longitudinal questionnaire was employed to study maternal 
fear of childbirth, delivery experience, and OD mothers’ and fathers’ mental 
health during their transition to parenthood. The study group consisted of 26 
OD women and their matched controls, 52 women who conceived with in 
vitro fertilisation/intra-cytoplasmic sperm injection (IVF/ICSI), and 52 
spontaneously conceiving women (SC). Matching to find controls was made 
according to mothers’ age, parity, plurality, and the number of returned 
questionnaires. 
The couples answered questionnaires three times: at 2nd trimester; 8 
weeks after the delivery; and when the child was one year of age. The 
questionnaires included questions about parents’ background. Fear of 
Delivery Questionnaire (FDQ) and Pregnancy Anxiety Scale (PAS) were used 
to measure level of fear of childbirth at 2nd trimester and the Delivery 
Satisfaction Scale (DSS) to assess delivery experience 8 weeks after the 
delivery. Furthermore, General Health Questionnaire (GHQ-36) was to be 
answered at all three time points to assess mental health symptoms of 
mothers and fathers. 
The level of fear of childbirth was lower among OD mothers than among 
IVF/ICSI mothers, but it did not differ significantly from SC mothers. 
Pregnancy-related anxiety was lower in OD mothers compared with both 
IVF/ICSI and SC mothers. Delivery experience was similar between the 
groups, but acute operative deliveries associated with dissatisfaction only in 
the OD mothers. 
Regarding mental health symptoms of mothers at 2nd trimester, no 
differences were found between the groups, but they differed at 8 weeks 
postpartum and one year after the delivery. OD mothers showed less anxiety 
than SC mothers at 8 weeks postpartum and when the child was one year old. 
Furthermore, OD mothers had fewer sleeping difficulties and less social 
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dysfunction than IVF/ICSI mothers at 8 weeks postpartum and when the 
child was one year of age but when OD mothers were compared with SC 
mothers, differences were found only at 8 weeks postpartum. Mental health 
symptoms of OD fathers did not differ from IVF/ICSI and SC fathers at any 
time point. 
Retrospective questionnaire studies provided information on parental 
disclosure intentions, experiences and attitudes after their OD treatment and 
insemination (DI) or IVF treatment with donated sperm (dIVF). 
Questionnaires were sent to mothers and fathers separately and included 
only heterosexual couples using donor sperm to the study. Parents were 
asked if they had already shared the information with the child about his/her 
genetic background and, if not, what were their intentions. Other questions 
were about the decision to use donated gametes, openness toward other 
people, concerns about the donor characteristics, experiences of counselling, 
and attitudes about Finland’s new Fertility law. These parents received 
treatment before the Finnish open-identity ART law came in act in 2007, 
which means that the donor offspring can ask identifying information of the 
donor at the age of 18. 
Answers were received from 68% (113/167) of OD mothers and 61% 
(100/163) of OD fathers, and 55% (139/252) of DI/dIVF mothers and 53% 
(127/239) of DI/dIVF fathers. Information was received from 164 OD 
children aged 1–14 years and 240 DI/dIVF children aged 1–22 years. 
Of OD parents, 60% had already told or intended to tell the child and 26% 
(aged 3-14) of children had already received the information about the way of 
their conception. Parents with younger children were more willing to disclose 
compared with parents in the oldest age group and this difference was 
statistically significant. 
Of DI/dIVF mothers, 41% and 36% of DI/dIVF fathers reported that 
they had either told or intended to tell the child about his/her donor 
conception. Of all children, 16% had received information and the majority 
of them had received it before and upon starting school. Again, parents 
with younger DI/dIVF children showed more openness toward the child 
compared with the parents with older children and the difference was 
statistically significant. 
Psychological support had been insufficient for 24% of OD mothers and 
11% of OD fathers, and less than half of DI/dIVF parents were satisfied with 
the psychological support they were offered. Of OD and DI/dIVF parents, 
40% reported that the new Finnish open-identity ART law will probably not 
impact on the disclosure intentions of future donor offspring parents. 
The results are encouraging. The psychological well-being of OD parents 
was good, and it creates therefore a strong basis for parenthood after all the 
challenges of becoming a mother and a father. Fears for the security of the 
long-wanted child did not overshadow OD mothers’ pregnancy and delivery, 
which might have been a risk for the mother-child relationship. Although 
parents seem to cope well during pregnancy and early parenthood, it is 
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unclear, in light of these results, what effect a child-related or other stressor 
has on parental psychological well-being. Parents are screened for their 
mental health problems and marital relations before the treatment, which 
partly explains the findings. There are still couples who need additional 
psychological support during pregnancy and early parenthood, and they 
should be recognised. 
One of the most important issues, and a potential stress factor for OD and 
DI/dIVF parents, is what to tell the child about his/her genetic background. 
General attitudes about donor treatments have changed over the years 
toward more acceptance and openness, and consequently, Finland among 
other countries enacted an open-identity law. This positive change in general 
attitudes has probably had an effect on the parents in this study because a 
tendency toward more openness was also found. Whether this tendency 
toward openness will continue under the new law remains to be seen. 
Both OD parents and DI/dIVF parents had very few concerns about the 
donor and all thought that the child feels like their own. These reassuring 
results may hopefully help infertile couples who need donated gametes to 
proceed with gamete donation treatment, overcome their fears of the 
unknown, and parent their long-wanted child. 
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TIIVISTELMÄ 
Luovutettujen sukusolujen käyttö lapsettomuushoidoissa on mahdollistanut 
raskauden ja lapsen vanhemmille, jotka eivät voisi saada lasta omilla 
sukusoluilla. Hoitomäärät lahjasukusoluilla kasvavat koko ajan 
maailmanlaajuisesta, ja joka vuosi tuhansia lapsia syntyy onnistuneen 
lahjasukusoluhoidon jälkeen. Tutkimuksia, joissa olisi tutkittu 
lahjasukusoluhoidolla raskaaksi tulleitten vanhempien mielenterveyttä 
raskauden aikana ja heti synnytyksen jälkeen, on hyvin vähän. Suurin osa 
tutkimuksista tähän asti on keskittynyt vanhemman ja lapsen välisiin 
suhteisiin. Keskeinen kysymys onnistuneen lahjasukusoluhoidon jälkeen on, 
mitä vanhemmat kertovat lapselle ja lähipiirille lapsen alkuperästä. 
Tämän väitöstutkimuksen tavoite oli selvittää äitien kokemaa 
synnytyspelkoa ja synnytyskokemusta onnistuneen lahjamunasoluhoidon 
jälkeen. Lisäksi selvitimme lahjamunasoluhoidolla raskaaksi tulleiden äitien 
ja heidän puolisoittensa mielenterveyttä raskausaikana ja synnytyksen 
jälkeen. Toisena tavoitteena oli selvittää, ovatko vanhemmat kertoneet 
lapselle tai aikovatko kertoa lapselle lahjasukusoluhoidosta lahjoitetuilla 
munasoluilla tai lahjasiittiöillä. Lisäksi halusimme tietoa, mitä vanhemmat 
ajattelevat hoitopäätöksestä aikanaan, luovuttajasta, psykologisesta tuesta ja 
tulevasta uudesta hedelmöityshoitolaista. 
Vanhempien mielenterveyttä ja äitien synnytyspelkoa ja -kokemusta 
tutkittiin kyselytutkimuksella. Tutkimusryhmä koostui 26 äidistä, jotka 
olivat tulleet raskaaksi lahjamunasoluilla. Heille haettiin kaltaistetut verrokit 
äideistä, jotka olivat tulleet raskaaksi omilla soluilla tehdyn 
koeputkihedelmöityshoidon (IVF/ICSI) jälkeen (n=52) ja äideistä, jotka 
olivat tulleet raskaaksi spontaanisti (n=52). Kaltaistus tehtiin äidin iän, 
pariteetin, sikiölukumäärän ja palautettujen kyselyitten suhteen. 
Vanhemmat vastasivat kolmeen kyselyyn: keskiraskauden aikana, 8 
viikkoa ja vuosi synnytyksen jälkeen. Synnytyspelkoa mitattiin raskausaikana 
Fear of Childbirth Questionnaire (FDQ) ja Pregnancy Anxiety Scale (PAS) 
avulla. Synnytyskokemuksen mittarina käytettiin Delivery Satisfaction Scale 
(DSS) kyselyä, joka tuli täytettäväksi 8 viikkoa synnytyksen jälkeen. Äitien ja 
isien mielenterveyttä tutkittiin General Health Questionnaire (GHQ-36) 
avulla kaikissa kolmessa kyselyssä. 
Lahjamunasoluhoidolla raskaaksi tulleet äidit kokivat vähemmän 
synnytyspelkoa kuin IVF/ICSI äidit, mutta tilastollista eroa suhteessa 
spontaanisti raskaaksi tulleisiin äiteihin ei saatu. Lisäksi raskauteen liittyvää 
ahdistusta lahjamunasoluhoidolla raskaaksi tulleet äidit kokivat vähemmän 
kuin verrokit. Synnytyskokemus oli samanlainen kaikissa kolmessa 
ryhmässä. Akuutti operatiivinen synnytys liittyi huonompaan 
synnytyskokemukseen lahjamunasoluhoidolla raskaaksi tulleilla äideillä, 
mutta ei verrokeilla. 
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Lahjamunasoluhoidolla raskaaksi tulleitten äitien mielenterveys oli 
raskausaikana samanlainen kuin verrokkiäideillä. 8 viikkoa synnytyksen 
jälkeen lahjamunasoluhoidolla raskaaksi tulleet äidit kokivat vähemmän 
ahdistusoireita verrattuna spontaanisti raskaaksi tulleisiin äiteihin. Heillä oli 
lisäksi vähemmän univaikeuksia ja ongelmia sosiaalisissa suhteissa kuin 
IVF/ICSI ja spontaanisti raskaaksi tulleilla äideillä. Vuosi synnytyksen 
jälkeen lahjamunasoluhoidolla raskaaksi tulleilla äideillä oli vähemmän 
ahdistusoireita kuin spontaanisti raskaaksi tulleilla äideillä ja vähemmän 
univaikeuksia ja ongelmia sosiaalisissa suhteissa kuin IVF/ICSI äidiellä. 
Isien mielenterveys oli samanlainen kuin verrokeilla keskiraskaudesta alkaen 
aina siihen asti kun lapsi oli yksivuotias. 
Vanhempien aikomuksia kertoa lapselleen lahjasukusoluhoidosta 
tutkittiin kyselytutkimuksella, joka lähetettiin niille äideille ja isille erikseen, 
joilla oli lapsi onnistuneen lahjasiittiöhoidon tai -munasoluhoidon jälkeen. 
Samalla kysyimme heidän kokemuksiaan hoitopäätöksestä aikanaan 
tarjotusta psykologisesta tuesta, huolista koskien luovuttajaa ja uudesta 
hedelmöityshoitolaista. Vanhemmat, jotka pyydettiin osallistumaan 
tutkimukseen, olivat saaneet hedelmöityshoitoa ennen uutta 
hedelmöityshoitolakia. Uuden lain mukaan kaikki luovuttajat rekisteröityvät 
eikä sukusolujen luovutus anonyyminä ole enää ollut mahdollista syyskuun 
2007 jälkeen. 
Lahjamunasoluilla lapsensa saaneista äideistä kyselyyn vastasi 68 % 
(113/167) ja isistä 61 % (100/163). Vastaavasti lahjasiittiöillä lapsensa 
saaneista äideistä vastasi 55 % (139/252) ja isistä 53 % (127/239). Saimme 
tietoa 164 lahjamunasolulla syntyneistä lapsista iältään 1-14 vuotta ja 240 
lahjasiittiöllä syntyneistä 1-22 vuotiaista lapsista. 
Noin 60% vanhemmista, joilla oli lapsi lahjamunasoluilla, oli kertonut tai 
aikoi kertoa lapselle hänen alkuperästään. Yli 3v ikäisistä lapsista 26% oli 
saanut jo tiedon. Ne vanhemmat, joilla oli nuorempia lapsia, olivat 
useammin avoimuuden kannalla kuin ne, joiden lapset olivat vanhempia 
tutkimushetkellä ja ero ryhmien välillä oli tilastollisesti merkitsevä. 
Lahjasiittiöillä lapsensa saaneista äideistä 41 % ja isistä 36 %, oli kertonut 
tai aikoi kertoa lapselleen lahjasukusoluhoidosta. Lapsista 16 % oli jo tiedon 
saanut ja suurin osa heistä oli sen saanut ennen kouluikää. 
Lahjasiittiöhoidolla lapsensa saaneiden vanhempien avoimuus oli 
suurempaa mitä nuorempi heidän lapsensa oli tutkimushetkellä kuin niillä, 
joiden lapsi oli jo vanhempi. Ero oli tilastollisesti merkitsevä. 
Lahjamunasoluhoidolla ja lahjasiittiöhoidolla lapsensa saaneilla 
vanhemmilla oli hyvin vähän huolta luovuttajan suhteen ja he kaikki 
raportoivat, että lapsi tuntuu omalta. Noin 24 % äideistä ja 11 % isistä 
lahjamunasoluhoidon jälkeen ja alle puolet vanhemmista lahjasiittiöhoidon 
jälkeen olivat tyytymättömiä tarjottuun psykologiseen tukeen hoitojen 
aikana. Noin 40 % kaikista vanhemmista vastasi, että uusi hedel-
möityshoitolaki ei tulisi todennäköisesti muuttamaan vanhempien 
suunnitelmia kertoa lapselle lahjasukusoluhoidosta. 
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Tutkimuksesta saadut tulokset ovat rohkaisevia. Tuloksemme osoittivat, että 
lahjamunasoluhoidolla raskaaksi tulleiden äitien ja heidän puolisoidensa 
mielenterveys on hyvä raskausaikana ja pian synnytyksen jälkeen. Lisäksi 
äidit raportoivat vähemmän synnytyspelkoa ja olivat pääasiassa tyytyväisiä 
synnytykseensä. Löydökset antavat hyvän pohjan vanhemmuudelle varsinkin 
kun yo. tekijöitä voidaan pitää riskitekijöinä vanhemman ja lapsen väliselle 
suhteelle. Tämä on erityisen tärkeää, kun äidin ja lapsen välillä ei ole 
geneettistä yhteyttä. Ennen lahjasukusoluhoitoja vanhemmat käyvät 
keskustelemassa psykologin kanssa, ja mikäli mielenterveyden ongelmia tai 
parisuhdeongelmia esiintyy, hoitoa lykätään tai luovutaan hoidosta. Tämä 
selittänee osaltaan tutkimuslöydöksiä. Tutkimuksesta ei saatu tietoa, miten 
onnistuneen lahjamunasoluhoidon jälkeen äidit ja isät voisivat, mikäli heillä 
olisi lapseen liittyviä tai muita stressitekijöitä elämässä. Vaikka vanhempia 
on valmisteltu perusteellisesti lahjamunasoluhoitoon, niin silti on pareja, 
jotka tarvitsevat lisätukea vanhemmuuteen, ja heidät tulisi tunnistaa. 
Vanhemmat joutuvat ottamaan kantaa, mitä kertoa lapselle taustalla 
olevasta hedelmöityshoidosta. Yleinen mielipide lahjasukusoluhoitoja 
kohtaan on muuttunut vuosien varrella avoimemmaksi. Totesimme, että 
mitä nuorempi lapsi oli sitä avoimempia vanhemmat olivat 
lahjasukusoluhoidosta. Sitä, muuttaisiko uusi laki vanhempien ajatuksia 
kertomisesta vielä avoimempaan suuntaan, olisi syytä tutkia tulevaisuudessa 
uuden lain voimassa ollessa. 
Ilahduttavaa oli todeta, että vanhemmilla oli hyvin vähän huolia 
luovuttajasta ja kaikki tunsivat, että lapsi on oma. Toivottavasti 
tutkimuksesta saadut tulokset auttavat hälventämään vanhempien huolia 
siitä, mitä lahjasukusoluhoito tuo tullessaan, ja he päättäisivät lähteä hoitoon 
ja saisivat kauan kaipaamansa lapsen. 
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1. INTRODUCTION 
Infertility affects approximately 3.5–16% couples of reproductive ages. It is 
defined as a failure to conceive over one year of unprotected timed 
intercourse (Boivin et al., 2007). In the youngest female age group (<25 
years) incidence of infertility is 6% and in women aged 40–45 it is 40% 
(Baird et al., 2005; Rothman et al., 2013). Advanced male age also (>40 
years) decreases ongoing pregnancy rates and increases risk for miscarriages 
(de la Rochebrochard et al., 2006). 
Infertility is categorised as female-specific in 25–47% of cases, male 
specific in 16–26%, due to combined reasons in 18%, and due to unknown 
causes in 12–30% of cases (Evers 2002). The most common reasons for 
female infertility are ovulatory dysfunction (34%), tubal (24%), 
endometriosis (11%) and others such as, immunological problems, cancer 
chemotherapy, and genetic reasons (American Society for Reproductive 
Medicine (ASRM) Practice committee opinion, 2012; Lindsay and Vitrikas, 
2015). 
The causes of male factor infertility are unknown for almost half of the 
cases reported (Iammarrone et al., 2003). Sperm production may be 
impaired due to a number of reasons, including, hypogonadotrophic 
hypogonadism, chromosomal or other genetic disorders, failure of the testes 
to descend, cancer treatments, drugs, and environmental toxins (Skakkebaek 
et al., 1994; Nieschlag et al., 2010; Jungwirth et al., European Association of 
Urology Guidelines, 2015). In addition, testicular obstruction, retrograde 
ejaculation, and impotence are related to disturbed sperm transportation. 
In developed countries, lifestyle factors such as female or male 
overweight, smoking, and anabolic steroid use negatively affect pregnancy 
results. The role of psychological stress as an etiological factor of infertility is 
controversial (Cesta et al., 2018), but it seems probable that stress can cause 
infertility problems by inhibiting the hypothalamus-pituitary-adrenal cortex 
axis (HPA axis), altering the concentration of fertility hormones, as well as 
cortisol, opioids, and melatonin. Stress also lowers testosterone levels with a 
secondary rise in LH and FSH, thus has an effect on sperm quality 
(Campagne, 2006; Bhongade et al, 2015). 
Assisted reproductive technology (ART), including in vitro fertilisation 
(IVF), intracytoplasmic sperm injection (ICSI), and frozen embryo transfer 
(FET), is the most effective treatment for all types of infertility leading to the 
birth of millions of children worldwide. Multiple pregnancies with higher risk 
of prematurity and the associated morbidity of fetuses were a major obstacle 
in the early days of ART. An increasing use of single embryo transfer (SET) 
strategies to reduce multiple pregnancies increased the chances of additional 
FETs and this has increased the cumulative pregnancy rate per oocyte 
retrieval (McLernon et al., 2016). 
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Although ART is a clinically effective treatment for many forms of infertility, 
it is not always possible to conceive with own gametes. Donated gametes are 
used when own gametes are missing, the quality is bad and when a woman 
has no partner and donated sperm cells are needed. The phrase “third-party 
reproduction” refers to the use of gametes that have been donated by a third 
person (donor) to enable an infertile individual or a couple to become 
parents. Third-party reproduction can be socially, ethically, and legally 
complex. As donation treatments have become more common, it is necessary 
to consider the impact of this technology on parents, their children, and the 
gamete donors. 
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2. REVIEW OF THE LITERATURE 
2.1. BACKGROUND AND USE OF DONATED GAMETES 
IN ART TREATMENT 
The first successful oocyte donation (OD) treatment was performed in 1984 
at Monash IVF Centre, Australia (Lutjen et al., 1984). Originally, it was 
developed to help women without ovarian function to conceive a child of 
their own. Very soon, the number of treatments started to grow and the 
indications for using donated oocytes expanded. Treatments now exceed 50 
000 annually in Europe (de Geyter et al., 2018) and 20 000 in the USA 
(Society for Assisted Reproductive Technology National Summary Report, 
2106). Over the three decades, OD has led to the birth of more than 200 000 
children (Woodriff et al., 2014). Every year in Finland, 700–800 cycles 
(Figure 1.) are performed using donated oocytes, leading to live birth of 150–
200 children (National Institute of Health and Welfare Statistics, 6/2018). 
Donor sperm use was first documented in 1884 at the Jefferson Medical 
Centre, Philadelphia, USA (Brewayes et al., 1996). In 1953, the first reported 
infant was born after successful treatment with frozen donor sperm 
(Steinberger and Smith, 1973). Methods for use of fresh and frozen sperm 
were developed in the early 1950s (Gregoire and Mayer, 1965). In Finland, 
frozen donor sperm has been used in fertility treatments at least from the 
beginning of the 1980’s. In the mid 1980’s, it was estimated that 100–150 
children were born every year with the use of frozen donated sperm cells 
(Iirola and Niemi, 1991). 
Nowadays in Finland the annual number of donor inseminations (DI) 
exceeds 1000, leading to the birth of about 150 children (Figure 2.). In 
addition, about 150 children are born from IVF treatments with donor sperm 
(National Institute of Health and Welfare Statistics, 6/2018). No statistics 
are available on donor IVF treatments in Europe. 
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Figure 1. 
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2.2. LEGISLATION 
Demands for donated cells are increasing as many couples are willing to 
choose gamete donation to overcome their infertility (Pennings, 2007). 
Fertility treatment with OD is allowed in most European countries, but 
legislation and clinical practices differ between the countries. In Germany 
and Norway, OD treatments are still prohibited by law. Gamete donation 
may be anonymous as is the case in France, Italy, Slovenia, and Spain or 
non-anonymous as in Finland, Sweden, and the UK. Non-anonymous 
donation means that donor identity is registered and can be released at a 
later time point to offspring. 
Due to differences in legislation, lack of donors in a patient’s home 
country, or searching for better quality care, people travel abroad to receive 
infertility treatments. It has been estimated that 11000–14000 patients in 
Europe travel outside their residence country each year to seek help for their 
infertility (Shenfield et al., 2010). 
In September 2007, Finland enacted a law on assisted fertility treatments 
(1237/2006). The law states that gamete donors must register their 
identifying information in an official donor registry kept by the national 
Authority for Medico-legal Affairs in Finland (Valvira). This enables 
offspring born after treatment with donated gametes to obtain identifying 
information about the donor upon reaching the age of 18 years, but no other 
legal rights or obligations exist. 
Donating gametes is a voluntary act and donors provide consent for the 
treatment which they can withdraw at any time. According to the 2007 ART 
law, the donor remains anonymous to the recipient couple and vice versa. 
Since fertility treatments with donor gametes started in Finland, it has also 
been possible for a recipient to choose a known person as a donor (a sister or 
a friend). Donors can also set limitations for the use of their gametes, for 
example with regard to female couples or single women. Gametes from one 
donor can be used as long as there are children born to no more than five 
families. 
2.3. OOCYTE DONATION TREATMENT 
Originally, oocyte donation treatment was used for patients with premature 
ovarian insufficiency (POI). The prevalence of POI is 0.3–1.0% in women of 
reproductive age and this risk increases with age. Etiological factors for POI 
are genetic, idiopathic, or acquired. The most common genetic causes of POI 
are Turner’s syndrome, Fragile X premutations, and various genetic defects 
in steroidogenic enzymes or gonadotrophic receptors. Acquired causes can be 
of autoimmune origin like autoimmune polyglandular syndromes or 
concomitant autoimmune diseases of thyroid, pancreas, or adrenals. 
Enviromental causes like toxins or viruses can be potential reasons for POI, 
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as well as cancer treatments (cytotoxic agents, radiation, pelvic surgery), but 
the vast majority of POI remains idiopathic. Symptoms of POI vary according 
to causes from primary amenorrea and ovulation dysfunction to clear 
menopausal symptoms like hot flushes and secondary amenorrea (Chae-Kim 
and Gavrilova-Jordan, 2018). Nowadays, oocyte donation is mostly used in 
women with repeated IVF failure, due to poor ovarian response or suspicion 
of oocyte abnormality, or to overcome peri-or postmenopause. 
2.3.1. MEDICAL TREATMENT 
The oocyte donor undergoes ovarian stimulation with gonadotropins (FSH, 
hMG). Follicle growth is monitored with vaginal ultrasound and 
gonadotrophin-releasing agonists (GnRH agonist) or gonadotrophin-
releasing antagonists (GnRH antagonist) are used to prevent premature 
ovulation. When the biggest follicles have reached a size of 17-20mm, the 
ovulation process is triggered with human chorion gonadotrophin (HCG) or 
GnRH agonist, to allow the oocytes to mature, and 36 hours later the oocytes 
are retrieved under ultrasound guidance and local anesthesia. The collected 
oocytes are fertilised with the sperm of the recipient’s male partner, or with 
donated sperm, in the laboratory to produce embryos. 
An embryo is replaced to the recipient’s uterus either in a fresh or a frozen 
cycle. In a fresh cycle, the menstrual cycles of the donor and the recipient 
need to be synchronised. The recipient’s endometrium is prepared for 
embryo transfer (ET) using either a GnRH analogue together with estradiol 
pills, patches or transcutaneous gel, or merely estradiol medication. 
Ultrasound scan is used to assess the thickness and configuration of the 
endometrium. Progesterone is usually started on the day of donor oocyte 
collection or 4–6 days before FET. If pregnancy is confirmed, hormonal 
replacement therapy (HRT) continues until 10-12 pregnancy weeks. 
    
     Figure 3 Synchronisation of donor and recipient cycles in oocyte donation treatment 
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2.3.1.1. Risks related to medical treatment 
 
Donors are exposed to hormonal treatment and potential complications 
related to oocyte retrieval. In a recent Finnish study, the most common 
complication noted was hyperstimulation in 5% of the treatment cycles 
(Söderström-Anttila et al., 2016). Other complications (intra-abdominal 
bleeding, infection, allergic reaction, bladder injury, cysts) related to egg 
collection were rare (0.2-1.0%). About 16% of donors experienced 
physical side effects (pain, bloating, menstrual changes, nausea) and 2% 
psychological side effects (Söderström-Anttila et al., 2016). In two other 
studies the complication rate has been <1% (Bodri et al., 2008; Maxwell 
et al., 2008). 
In a follow up study from the United States, 16 % of past donors reported 
long-term physical symptoms (infertility, cysts, fibroids, weight gain) and 
20% some psychological consequences afterwards (Kenney and McGovan, 
2010). In a Finnish study of 400 donors, over 90% experienced no harmful 
long-term general health effects. The treatment has not been found to have 
any negative effects on the donors’ own fertility (Kramer et al., 2009; Stoop 
et., al 2012; Söderström-Anttila et al., 2016). 
2.3.2. PREGNANCY OUTCOME 
 
Treatment with donated oocytes has been associated with the highest 
pregnancy rates among all types of ART. According to the last statistics 
from Finland, pregnancy rate per embryo transfer (ET) was 48% and live 
birth rate 33% (National Institute of Health and Welfare Statistics, 6/2018). 
The pregnancy rate after fresh ET was 50% in Europe and 50% in the USA 
(Society for Assisted Reproductive Technology National Summary Report, 
2107; de Geyter et al., 2018). After frozen embryo transfer (FET) the rate 
was 38% in Europe and 41% in the USA. In Finland, the great majority of 
OD embryo transfers are SETs. In Europe, every 4th pregnancy is a multiple 
pregnancy starting from ETs with two or three embryos (Society for 
Assisted Reproductive Technology National Summary Report, 2107; de 
Geyter et al., 2018). 
The reason for the high success rate is the use of high-quality oocytes 
from younger women. A recipient woman’s uterus can usually be prepared 
with hormones for embryo implantation, irrespective of the age of the 
recipient and therefore pregnancy results are similar in different age 
groups. Furthermore, the results are not dependent on the indication for 
treatment (Gupta et al., 2012). Factors that may decrease probabilities for 
pregnancy are a thin (< 5mm) endometrium (Arce et al., 2014), recipient’s 
overweight (Bellver et al., 2013) and male partner’s low sperm quality 
(Girsh et al., 2008). 
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2.3.3. OBSTETRIC AND PERINATAL OUTCOMES 
 
Studies on obstetric outcomes have revealed an increase in incidence of pre-
eclampsia and pregnancy induced hypertension (Serhal et al., 1989; Pados et 
al., 1994; Söderström-Anttila et al., 1998; Storgaard et al., 2016). 
Hypertensive disorders of pregnancy (pregnany induced hypertension, 
chronic hypertension, pre-eclampsia, and HELLP syndrome) is one of the 
major causes of maternal morbidity and mortality and may lead to stillbirth, 
preterm, or small-for-gestational-age babies (Sibai et al., 2005; Backes et al., 
2011; Pennington et al., 2012). Furthermore, studies have revealed higher 
incidence of low birth weight (LBW), preterm birth (PTB), and caesarean 
section (CS) in OD pregnancies than autologous IVF pregnancies 
(Söderström-Anttila et al., 2001; Malchau et al., 2013; Nejdet et al., 2016). A 
recent systematic review and meta-analysis on obstetric and neonatal 
complications in OD pregnancies versus conventional IVF/ICSI found that 
the risk for pre-eclampsia was elevated both in singleton (AOR 2.1, CI 1.42–
3.15) and in multiple pregnancies (AOR 3.31, CI 1.61–6.80). Furthermore, 
the risk for PTB and LBW was higher in singletons (AOR 1.75, CI 1.39–2.20) 
and multiple pregnancies (AOR 1.53, CI 1.16–2.01), respectively (Storgaard et 
al., 2016). Savasi et. al., (2016) reported similar results in their review article. 
One explanation for the increased obstetric complications in OD 
pregnancies is immunological maladaptation, which in turn causes placenta 
disorders like villitis of unknown etiology (Styer et al., 2003), chronic 
deciduitis (Gundogan et al., 2010), chronic intervillositis (Boyd and Redline 
2000), and maternal floor infarction (Katzman and Genest, 2002). In 
addition, in an animal work, hormonal preparation of endometrium may 
suppress trophoplastic remodeling of the uterine spiral arteries and have an 
impact on blood circulation (Aberdeen et al., 2012). 
Most OD recipients are older than 40 years, and nulliparity and multiple 
pregnancies further increase pregnancy risks. In a recent French study, 
recipients older than 50 years did not differ in pregnancy complications 
from recipients aged 45–50 years although complication rates were high in 
both groups (Guesdon et al., 2017). Infertility and ovarian insufficiency 
have also been suggested to be explanatory factors for higher obstetric risks 
(Krieg et al., 2008). 
The risk to give birth with CS is higher after OD treatment than after 
conventional IVF/ICSI (OR 2.20; CI 95% 1.85–2.60) or after a spontaneous 
pregnancy (OR 2.38; CI95% 2.01–2.81) (Storgaard et al., 2016). Indications 
for CS are seldom reported in the studies, but it might have to do with 
planned caesareans. Furthermore, the risk of having a postpartum 
hemorrhage in a singleton OD pregnancy is 4–17%, which is higher than in 
IVF/ICSI pregnancy with autologous oocytes (Storgaard et al., 2016). 
Women should be screened carefully before treatment to avoid obstetrical 
complications and SET is recommended in OD programs (Clua et al., 2012; 
Savasi et al., 2016). There are only a few studies available on long-term 
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physical consequences later in life for a child or mother after an OD 
pregnancy. Williams et al. (2018) recently reported no overall risk of cancer 
in a cohort of 12 000 children born after donor ART. 
 
Figure 4. Factors affecting obstetric and perinatal outcome of oocyte donation pregnancies 
2.3.4. OOCYTE BANK TREATMENT 
Due to improvements in cryopreservation of oocytes (vitrification), human 
oocytes can be stored safely for infertility treatments. In 2014, the American 
Society for Reproductive Medicine (ASRM) stated that oocyte freezing is not 
to be regarded as an experimental method (ASRM Practice committee 
guideline, 2013) and nowadays OD treatments with vitrified oocytes are 
exceeding rapidly. The first experiences from a commercial donor egg bank 
was published by Akin et al in 2007. A recent retrospective study of 30 000 
donor cycles found that fresh donor oocytes produced better live birth rates 
than frozen oocytes (51% vs. 40%) (Kushnir et al., 2018). Studies have shown 
no differences in birth weight and congenital malformations when 
pregnancies had started with fresh oocytes compared to conventional 
IVF/ICSI treatment and spontaneous conception (SC) (Chian et al., 2008; 
Noyes et al., 2009; Cobo et al., 2014). Seshadri et al. (2018) found no 
significant differences in obstetrical outcomes after using vitrified donor 
oocytes and fresh autologous oocytes. Studies on usage of vitrified donor 
oocytes and longterm consequences for the child are not yet available. 
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2.3.5. ASPECTS RELATED TO AN OOCYTE DONOR 
2.3.5.1. Donor profile 
World-wide there are different types of oocyte donors depending on the 
legislation in different countries. Non-patient donors can be voluntary, 
altruistic donors who donate without financial compensation, known donors 
(donating to a known recipient), or commercial donors receiving a monetary 
reward (Purewal and van den Akker, 2009). Commercial donors are common 
in the USA, but monetary compensation is prohibited in many European 
countries. Since 2007, Finnish oocyte donors are reimbursed for their 
expenses and inconvenience of the treatment with an extra payment of 250€. 
Patient donors are women undergoing their own IVF treatment (egg 
sharing), donating some of the collected oocytes to the OD program in order 
to subsidise their own treatment. 
Socioeconomic and fertility-related characteristics of the oocyte donors 
vary across European countries. According to an epidemiological study from 
Europe, the mean age of the oocyte donors was 27 years, 49% were 
employed, 16% unemployed, and 15% were students (Pennings et al., 2014). 
Pennings et al. (2014) concluded: “The general oocyte donor profile was well-
educated woman living with her partner and child/children”. Typical 
characteristics for a Finnish oocyte donor are that she is highly educated, 
cohabiting or married, and motivated by pure altruism (Pennings et al., 
2014). In a large cross-sectional study of all oocyte donors at the 
Väestöliitto’s clinics during more than 20 years, the general profile and the 
mean age among donors before and after the 2007 ART act were similar. 
However, there was a tendency towards younger and more childless donors 
and more students and unemployed donors after 2007 (Söderström-Anttila 
et al., 2016). 
2.3.5.2. Motivation to donate 
Most oocyte donors have more than one motivation for donating their 
oocytes. Altruistic donors are purely motivated by their wish to help others 
(Söderström-Anttila, 1995; Purewal and van den Akker, 2009; Svanberg et 
al., 2012). Commercial donors are motivated by a wish to help but also by 
financial gain (Purewal and van den Akker, 2009). Other reasons for 
commercial donors have been a wish to get information about their own 
fertility (Jordan et al., 2004) and a wish to transmit their genes (Kalfoglou 
and Gittelsohn, 2000; Jadva et al., 2011). Known donors also donate to help 
their friend or a family member (Raoul Duval et al., 1992; Kalfoglou and 
Gittelsohn, 2000; Yee et al., 2007). Altruism and self-interest are 
motivations for patient donors, who believe it is a win-win situation for all 
parties (Ahuja et al., 1997; Blyth, 2004). 
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According to the before-mentioned study from 11 European countries, the 
motivations of the oocyte donors were pure altruism 48%, altruism and 
financial 34%, purely financial 11%, own treatment and altruism 6%, and 
own treatment 2% (Pennings et al., 2014). The highest level of altruism was 
found in France (100%), Finland (89%), and Belgium (86%). 
2.3.5.3. Experience of donating oocytes 
In general, oocyte donors’ experiences are reported to be positive, medical 
procedures are well tolerated, and satisfaction after donation is excellent 
(Bracewell-Milnes et al., 2016). Although there are some differences between 
donor types, high levels of satisfaction among all donors have been reported 
in several studies (Söderström-Anttila, 1998; Jordan et al., 2004; Purewal 
and van den Akker, 2009; Kenney and McGowan, 2010; Skoog Svanberg et 
al., 2013). In Finland, 99% of past donors expressed high satisfaction with 
their decision to donate and 95% would recommend it to other women. Only 
1% (4/428) of the donors had later regretted participation. Of the donors, 
10% reported that they would have liked more support before and after the 
donation (Söderström-Anttila et al., 2016). 
A systematic review of experiences of past oocyte donors has shown that 
the majority were interested in knowing the pregnancy outcome and even 
having contact with the offspring (Purewal and van den Akker, 2009). In a 
recently published Finnish study of oocyte donors reported that most 
voluntarily registered and open-identity donors welcomed or were neutral to 
potential contact with their donor offspring but were slightly more cautious 
towards contact between their own children and a donor-conceived child 
(Miettinen et al., 2019). 
2.4. SPERM DONATION TREATMENT 
Donor sperm has been used to overcome the challenges faced due to severe 
male factor infertility, and by female same-sex couples and single women. 
Azoospermia is defined as an absence of sperm cells in an ejaculate in at least 
two separate sperm analysis. Azoospermia is found in 1% of all men and 10–
15% of infertile men. Endocrine causes for azoospermia/severe 
oligotsoospermia are hypogonadotrophic hypogonadism (Kallmann’s sdr, 
pituitary trauma or tumour, use of anabolic steroids), hyperprolactinemia, 
and androgen resistance due to genetic reasons. Other causes for 
azoospermia/severe oligotsoospermia are testicular in origin, including 
varicocele, undescendended testicles, mumps orchitis, toxins and 
medications, and chromosomal disorders, most commonly Klinefelter 
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syndrome or y-chromosome microdeletions. Retrograde ejaculation and 
obstructive reasons like cystic fibrosis may also cause this problem (Coccuza 
et al., 2013). 
A male donor gives sperm samples several times (10–12) to be stored 
frozen. On some occasions, fresh donations are made at the time of female 
recipient’s ovulation or oocyte collection in connection with IVF. There are 
no medical risks for the sperm donor involved in the process. 
There are three different types of sperm banks according to their 
operation subject, administrative structure, and budget source. Sperm banks 
may be mainly national like in the UK and France, mainly public like in 
Japan, and mainly commercial like in the USA and Denmark, or mixed like 
in Finland. Apart from providing donor sperm for fertility treatments, banks 
restore sperm for fertility preservation for cancer patients, as well as for 
high-risk professionals, transsexuals, and for men before vasectomy. 
2.4.1. PREGNANCY OUTCOME 
In Finland, the number of treatments using donor sperm has been increasing 
during the last decade. In 2006, 758 DI inseminations were carried out 
compared with 1080 treatments in 2017 (National Institute of Health and 
Welfare Statistics, 6/2018). The success rate of the treatment is dependent 
on the age of the recipient woman. Insemination resulted in pregnancy in 
15–18% of treatments performed in women < 40 years of age compared with 
5–12% in those over 40 years of age. Comparable results were reported in 
Europe where almost 50 000 AID cycles were done in 2014 and delivery rate 
per cycle was 12% (de Geyter et al., 2018). 
In Finland in 2016, 620 IVF treatments with donor sperm were started, 
leading to a live birth rate of 23% (National Institute of Health and Welfare 
Statistics, 2017), and 1125 donor inseminations lead to a live birth rate of 12%. 
2.4.2. OBSTETRIC AND PERINATAL OUTCOME 
Information about obstetric and perinatal outcomes after the use of donor 
sperm in ART is limited. Some concerns have been raised when 
cryopreserved sperm have been used in DI and donor IVF treatments. 
Perinatal outcome might be adversely affected by mechanisms such as 
oxidative stress on sperm cells during cryopreservation, which increases the 
risk of DNA fragmentation (Ribas-Maynoy et al., 2014). Furthermore, use of 
donor sperm is an immunologic challenge for a woman and increases the risk 
for pre-eclampsia compared with using a partner’s sperm (OR 1.63, 95% CI 
1.36-1.95) (Gonzalez-Comadran et al., 2014). The underlying mechanism 
remains unclear. 
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A systematic review comparing donor sperm neonates and spontaneously 
conceived neonates found similar prevalence of LBW, PTB, and birth defects 
in both groups (Adams et al., 2017). The same researchers analysed almost 
300 000 birth outcomes of children born after DI in 1996–2002 in Australia. 
Infants born after the use of donor sperm did not differ from their 
spontaneously conceived controls in mean birth weight, LBW, preterm 
delivery, or small or large for gestational age. They were, however, more 
likely to be born preterm with LBW, but these findings were partly 
attributable to multiplicity (Adams et al., 2017). A study from France 
reported no differences in birth defects and chromosomal abnormalities 
between donor sperm and SC children accordingly (Lansac and Royere, 
2001). Recently Gerkowicz et al. (2018) published a study of perinatal 
outcome in donor IVF cycles compared with non-donor IVF cycles and found 
that outcomes were clinically similar, but LBW delivery was slightly lower in 
donor sperm cycles. 
2.4.3. ASPECTS RELATED TO A SPERM DONOR 
General opinions in Western societies towards sperm donation are positive 
and it regulates men’s willingness of seeking to be a gamete donor. A study 
from Belgium asked a thousand male students about their attitudes towards 
sperm donation. Of respondents, 34% would consider donating sperm, 86% 
had positive attitudes, and 14% had neutral or negative attitudes (Provoost 
et al., 2018). 
2.4.3.1. Demographics and motivation to donate 
According to a systematic review, the demographic characteristics of sperm 
donors and persons considering donating sperm did not much differ from 
those who were against donating (Van den Broeck et al., 2013). Freeman et 
al. (2016) collected information on donors (n=383) who had registered 
online in a connection website for donors and recipients (Donor Sibling 
Registry). Of the donors, 80% were heterosexual, the mean age was 36 years, 
59% had a university degree, 70% were employed full-time, and about 50% 
were single and childless. In another study gathering information of open-
identity sperm donors from all fertility clinics in Sweden, the mean age was 
34 years, 42% were married and 18% lived in a relationship, 68% had an 
university education, and 65% had biological children (Skoog Svanberg et al., 
2013). 
Contradictory results have been found concerning motivations to donate 
(Van den Broeck et al, 2013). Altruism, a pure wish to help others, was the 
most significant motive to take part. In addition, financial compensation, 
investigating their own fertility status, and appreciation of own genes served 
as motivating factors for actual donors (Daniels et al, 2005; Riggs and 
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Russel, 2010; Jadva et al, 2011). Studies have found that a minority of sperm 
donors would have wanted their partners to take part in the decision-making 
process to donate. Partner involvement was welcomed in general, but men 
thought that they did not need their partner to provide consent for sperm 
donation (Lalos et al., 2003; Thorn et al., 2008). 
2.4.3.2. Experience of donating sperm cells 
There is little information available on how sperm donors have experienced 
the process to be a gamete donor. Skoog Svanberg et al. (2013) reported that 
the overall experience of open-identity donors was positive. Those donors 
who were ambivalent about the donation were less satisfied. Very few knew 
the outcome of the donation. However, most donors were satisfied with the 
information received from the staff. The same researchers have reported 
earlier that of potential donors, 50% said they would want to know the 
outcome of the treatments (Svanberg et al., 2003). 
2.5. PREGNANCY AS A PSYCHOLOGICAL PROCESS 
For most mothers, pregnancy and giving birth to a child is a powerful 
emotional and physical experience. During pregnancy, parents prepare for 
parenthood and create a bond with the infant (Broden, 2006). Transition to 
motherhood has been found to start at a very early stage of pregnancy and to 
be completed months after the birth of the child (Darvill et al., 2010). The 
psychological process in the transition to motherhood has two themes: a 
pregnant woman reorganizes her self-identity to be a mother and develops a 
relationship with the fetus (Broden, 2006; Raphael-Leff, 2001). Becoming 
mother explores her experiences of motherhood, most importantly with her 
own mother. In addition, she explores expectations of surrounding society 
for the role of motherhood (Stern, 1995). 
To be able to form a relationship with the fetus, a woman has to imagine 
an unborn infant as a separate individual from herself (Raphael-Leff, 2001). 
It is a continuum from the woman’s attention on her own body and physical 
changes to the fetus and the real baby (Raphael-Leff, 2001). As soon as a 
pregnant woman starts to prioritize the baby’s needs above her own, she also 
sees herself as a mother (Fonagy & Target, 1996). 
For men the psychological process to fatherhood starts also during 
pregnancy but it is fundamentally different when fathers do not become 
pregnant. They feel emotional distance with the fetus but at the same time a 
desire to form an emotional bond with the infant (Genesoni and Tallandini, 
2009). Father identity is based on their experiences and expectations of 
fathering from their surrounding environment. Furthermore, men have to 
redefine themselves with the relationship with their partner (Genesoni and 
Tallandini, 2009). 
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2.6. FEAR OF CHILDBIRTH AND PREGNANCY-RELATED 
ANXIETY 
Mild to moderate fear-of-childbirth and pregnancy-related anxiety is 
common and can be considered as normal (Areskog et al., 1981; Melender 
2002). For 6–14% of mothers, fear-of-childbirth becomes a problem and it 
appears to have increased in recent years (Areskog et al., 1981: Söderquist et 
al., 2004; Rouhe H et al., 2009; O’Connell et al., 2017). Moderate fear-of-
childbirth and pregnancy-related anxiety are more common among 
primiparous than parous women (Areskog et al., 1982; Alehagen et al., 2001; 
Saisto et al., 2001; Johnson and Slade, 2002; Söderquist et al., 2004). 
The background of fear of childbirth can be fear of pain, psychological 
(related to personality, previous traumatic events, or fear of future 
parenthood) or it can be due to lack of support or economic uncertainty or it 
can orginate from previous childbirth experiences. 
Fear of giving birth to a child is a special form of anxiety and distress 
(Rouhe et al., 2009). Pregnancy-specific anxiety is concern about fetal 
normality and well-being, the potential for the childbirth to damage the 
infant, and being separated from the baby. General anxiety and depression 
were strongly associated with fear of childbirth in an unselected group of 
pregnant women (Saisto et al., 2001; Laursen et al., 2008; Rouhe et al., 
2009; Storksen et al., 2012). Other predisposing factors for fear-of-childbirth 
are psychiatric disorders, negative life experiences, lack of social support, 
unemployment, and dissatisfaction with partnership (Areskog et al., 1982; 
Saisto et al., 2001; Söderquist et al., 2004; Rouhe et al., 2011; Dencker et al., 
2018). A recently published review article of fear of childbirth concluded that 
primiparous and multiparous women have separate reasons for fear but 
similar levels of fear of childbirth (Dencker et al., 2018). The most common 
reasons for fear-of-childbirth in parous women are previous complicated or 
operative deliveries (Saisto et al., 1999; Storksen et al., 2013). 
Previous infertility itself does not appear to increase fear-of-childbirth, 
but a long duration of infertility is a risk factor for severe fear (Saisto et al., 
1999; Poikkeus et al., 2006). In some studies, women conceiving through 
ART have reported higher anxiety about the outcome of pregnancy compared 
with spontaneously conceiving women (McMahon et al., 1997; Hammarberg 
et al., 2008). However, a large Finnish cohort study found no differences in 
fear of childbirth in women conceiving after ART or spontaneously (Poikkeus 
et al., 2006). 
Fear-of childbirth may complicate and prolong labour (Adams et al., 
2012). It may also increase posttraumatic stress disorder (Söderquist et al., 
2009) and risk of depression in the postpartum period (Räisänen et al., 
2013). Furthermore, fear of childbirth may impair maternal attachment with 
the fetus during pregnancy (Lindroos et al., 2015). 
Studies on fear-of-childbirth among women who have conceived with 
donated gametes have thus far been lacking. 
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2.7. CHILDBIRTH EXPERIENCE 
Sense of security and control, experienced level of labour pain and analgesia, 
personal support, support from hospital personnel, information given, and 
participation in decision-making contribute to the childbirth (Green et al., 
1990; Waldenström, 1996; Hodnett et al., 2002; Hodnett et al., 2007). 
Unplanned medical interventions during childbirth and operative delivery 
are strongly related to maternal dissatisfaction of delivery (Waldenström 
1996; Ryding et al., 1997; Waldenström et al., 2004; Wiklund et al., 2008). 
Low educational level, poor social support, dissatisfaction with the 
partnership, fear-of childbirth, and most of all intolerable pain during the 
childbirth, increase the risk of dissatisfaction of childbirth (Saisto et al., 
2001; Waldenström et al., 2004; Waldenström et al., 2006). 
Very little is known about the childbirth experience of women conceiving 
with ART. These few studies suggest that the childbirth experience is as good 
as or more satisfactory among ART women that spontaneously conceiving 
women (van Balen et al., 1996; Poikkeus et al., 2014). This implies that a 
demanding infertility process may help mothers to deal with unexpected and 
complicated delivery outcomes (Repokari et al., 2006). Prenatal depression 
and fear of childbirth may increase the risk for mothers’ dissatisfaction of 
childbirth. Among women conceiving with ART, these risks have been shown 
to be lower or similar to those experienced by spontaneously conceiving 
women (Klock and Greenfeld 2000; Repokari et al., 2005). 
ART conceiving women are more vulnerable for the potential risks for 
their long-wanted child (Hjelmstedt et al., 2003). Furthermore, due to 
delivery complications ART women reported more negative experiences, 
such as feeling out of control, suffering from separation from the baby, and 
postoperative pain (Hammarberg et al., 2008). Dissatisfaction with delivery 
associates with difficulties feeding the infant and anxiety about infant care 
(Rowe-Murray et al., 2001; Waldenström et al., 2004; Fisher et al., 2012). 
 
2.8. MENTAL HEALTH OF PARENTS AFTER ART 
Parental psychological adjustment is associated with children’s psychological 
development and is therefore an important aspect of family functioning 
(Blake et al., 2014). Prenatally depressed mothers can experience negativity 
towards the pregnancy and difficulties in developing fetal attachment 
(Seimyr et al., 2009). Depressive mothers behave less positively towards 
their newborn children than do women with no depression (Dix et al., 2014). 
Anxious mothers are found to behave less warmly, less positively and 
being more critical towards the child than non-anxious mothers (Whaley 
et al., 1999). 
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The influence of a father’s psychological adjustment on family functioning 
and the child has not received the same attention as that of a mother’s. A 
meta-analytic review concluded that psychological adjustment on a father’s 
parenting has the same effect as that of a mother’s (Wilson and Durbin, 
2010). 
Pregnancy after infertility brings great joy to the parents, but it may still 
be problematic. Infertility and ART treatments cause distress for many 
couples (van Balen et al., 1996; McMahon et al., 1997; Verhaak et al., 2005). 
Infertility is known to have a greater emotional impact on women than on 
their spouses (van Balen et al., 1996, Hjelmstedt et al., 1999). Negative 
feelings about infertility have been reported to persist even when they have 
become parents (Hjelmstedt et al., 2003; Verhaak et al., 2007). 
ART women are at increased risk for anxiety, depression, and 
psychological distress during the pregnancy (van Balen et al., 1996; 
McMahon et al., 2013; Garcia-Blanco et al., 2018). However, there are 
reports of no difference in levels of depression and anxiety, or the levels have 
been lower, among ART women compared to spontaneously conceiving 
women (Klock and Greenfeld, 2000; Repokari et al., 2005; Punamäki et al., 
2006; Hammarberg et al., 2008; Gourounti et al., 2016; Salih Joelsson et al., 
2017). Infertile women may idealise the pregnancy (Hammarberg et al., 
2008), but may also find their pregnancy more stressful for fear of pregnancy 
risks or losing the infant (Hjelmstedt et al., 2003). Despite pregnancy risks, 
women who conceived through ART perceived their pregnancies to be more 
rewarding and they had less worries about their body changes, child’s 
gender, and loss of freedom in their lives than controls (Hjelmstedt et al., 
2003; Klock and Greenfeld, 2000; Gourounti, 2016). 
Women with earlier depression or distress have higher risks for 
postpartum depression. Some studies have found that women who had 
received infertility treatments were at greater risk for postpartum depression 
(McMahon et al., 1997; Monti et al., 2008), but other reports contradict this 
(Klock and Greenfeld, 2000; Lynch et al., 2014). One study of mother’s 
adjustment to parenthood found significantly increased risk for parenting 
difficulties among women following ART (Fisher at al., 2012). Some have 
found instead no differences or fewer adjustment difficulties between ART 
and SC mothers (Repokari et al., 2006; Hammarberg et al., 2008; 
Jongbloed-Pereboom et al., 2012). 
Knowledge of psychological well-being of fathers during pregnancy and 
thereafter is limited (Hammarberg et al., 2008). Van Balen et al., 1996 found 
that infertile fathers experience more joy about their wives’ pregnancy than 
their fertile controls, but at the same time they considered the pregnancy 
experience to be stressful. Two studies have reported higher general anxiety 
antenatally among infertile men compared with fertile controls (Gibson et al., 
2000; Glazebrook et al., 2001). Hjelmstedt et al. (2003), in turn, found lower 
levels of somatic anxiety and indirect aggression among infertile men than 
their fertile controls, but at the same time infertile men were more anxious 
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about the progress of their partner’s pregnancy. Lower levels of antenatal 
depressive symptoms have been reported among infertile men compared 
with spontaneously conceiving controls (Glazebrook et al., 2001; Repokari et 
al., 2006) and these symptoms remained low also in the post-partum period. 
ART father’s adjustment to parenthood was similar to fathers whose partners 
conceived spontaneously (Hammarberg et al., 2008). 
 
 
2.9. MENTAL HEALTH OF COUPLES CONCEIVED WITH 
DONATED GAMETES 
Parents who conceive with donated gametes have a different route to 
parenthood because they have experienced infertility and undergone 
infertility treatments, possibly for several years. They have gone through an 
intense deciding process to proceed to gamete donation. Furthermore, they 
may have feelings of grief and loss because the child is not their shared 
genetic offspring. 
Women waiting for OD treatment experience emotional, sexual, and QOL 
impairments (Chen et al., 2004; Carter et al., 2011). Indekeu et al. (2012) 
compared male well-being and motives for parenthood among men starting 
treatment with insemination using their own sperm or donor sperm and they 
found that men in donor sperm treatment had higher expectations of 
parenthood, lower self-esteem, and more guilt. 
General parenting stress level among donor conceiving parents has been 
reported to be in line with that of spontaneously conceived parents (Blake et 
al., 2014). Most psychological studies of gamete donation families have 
focused on the parent-child relationship or on children’s psychological well-
being from early childhood to adolescence (Golombok et al. 2011, Blake et al., 
2014). Studies have shown that these children and parents are well-adjusted 
in all family types examined (sperm donation, OD, and surrogacy families). 
Absence of a genetic link between a parent and the child was not associated 
with negative relationship between a parent and a child (Golombok et al., 
2017; Zadeh et al., 2018). A follow up study of over 10 years from UK showed 
that majority of donor conception parents’ reported normal levels of 
depression, anxiety, and parenting stress (Blake et al., 2014). 
Issues of disclosure with the donor conceived child and closest family 
members has an influence on parental psychological well-being. Several 
studies have reported no differences in parental psychological well-being 
between non-disclosing and disclosing families (Nachtigall et al., 1997; 
Golombok et al., 2002; Lycett et al., 2004). However, there are also other 
contrasting reports. In one British study, secrecy was associated with higher 
levels of psychological functioning for the fathers (Blake et al., 2014). Family 
secrets may cause higher levels of anxiety (Lane and Wegner, 1995) but on 
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the other hand disclosing the secret may be psychologically damaging 
(Caughlin et al., 2009). Parental disagreement over what to tell the child 
about the donor conception did not increase parental stress when the child 
was young, but it became relevant when the child grew older (Gebhardt et al., 
2017). Couples conceiving with donated gametes have reported satisfaction 
with their relationship and it is considered as support system for parents 
(Blake et al., 2012; Sydsjö et al., 2014). 
 
 
2.10. INFORMING THE CHILD ABOUT THE WAY OF 
CONCEPTION 
In the early days of donor gamete treatments, children conceived with 
donated gametes had generally not been told about the nature of the 
conception. The assumption was that they would not benefit from knowing of 
their genetic origin (Golombok et al., 1996; Brewayes et al., 1997). In the 
1990’s attitudes started to shift towards openness, which was partly based on 
experiences of both adult offspring and adoptive children (Turner and Coyle, 
2000). Counselling practice moved slowly from secrecy to favouring 
openness (Daniels and Taylor 1993). In 2004, The Ethics Committee of the 
American Society for Reproductive Medicine (ASRM) noted that professional 
opinion has moved towards acceptance of identity disclosure to children and 
changed their recommendation from anonymous donation in 1993 to 
accepting non- anonymous donation. The Human Fertilisation and 
Embryology Authority (HFEA), expressed its opinion in favour of disclosure 
in 2008 (Crawshaw, 2008). 
Finally, a trend towards open-identity gamete donation led several 
countries to introduce legislation allowing only identifiable donors (Frith and 
Blyth, 2007). Sweden was the first country to introduce open-identity 
legislation in 1985. Later, various systems of open-identity donation were 
carried out in the USA, Austria, Switzerland, Australia, The Netherlands, 
New Zealand, and the UK (Daniels et al., 1995; Scheib et al., 2003; Lycett et 
al., 2005; Janssens et al., 2006; Lalos et al., 2007). Finland enacted its ART 
law in September 2007. Fertility treatment using gametes from open-identity 
donors provides donor offspring the right to information about his/her 
genetic origin at the age of 18 years (1237/2006). 
Studies have shown an increasing frequency of parents that have decided 
to share information about the donor treatment with their child (Gottlieb et 
al., 2000; van den Akker, 2006; Lalos et al., 2007; Isaksson et al., 2012; 
Applegarth et al., 2016; Tallandini et al., 2016). Parents, donors, and donor 
offspring may have different interests and opinions on disclosure issues. 
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2.10.1. FACTORS INFLUENCING DISCLOSURE OF DONOR 
CONCEPTION 
To disclose the donor conception or not may be the most challenging 
question for the parents when considering treatment with donor gametes 
(Daniels et al., 2011). The disclosure decision is not an one-time act, but an 
ongoing process. 
In a systematic review, Indekeu et al. (2013) reported several factors 
contributing to parental decision-making in disclosing donor conception, 
such as parents own beliefs and values, interpersonal factors (couple 
dynamics, grandparents’ attitudes, family composition), an impact of health 
care staff and support groups, and sociocultural factors. However, the impact 
of legislation on disclosure is unclear. Younger parents’ intention to disclose 
was higher than that of older ones after OD treatments (Baetens et al., 2000; 
Hahn and Craft-Rosenberg, 2002). The impact of social class and education 
level on the parents’ decision to inform their child or not about the donor 
conception is inconclusive. According to some researchers, no association 
has been found (Nachtigall et al., 1997; Greenfeldt and Klock, 2004). 
Brewaeys et al. (1997) observed that higher education favours disclosure, but 
contradictory results have also been reported (Rosholm et al., 2010). In a 
lower socioeconomic context, nondisclosure is more common if male 
infertility is present (Brewaeys et al., 2005). 
According to some studies, intention to tell the child about the use of 
donated sperm has not shown any gender differences between mothers and 
fathers (Brewayes et al., 1997; Nachtigall et al. 1997). However, others have 
observed that women tend to be more open than men with regard to 
disclosure both to the offspring and to other people (Daniels et al, 1995; 
Klock and Greenfeld, 2004; Mac Dougall et al., 2007; Shehab et al., 2008; 
Isaksson et al., 2011). Parents who are feeling uncomfortable with their 
decision to use donor gametes to resolve their infertility problem, are less 
likely to inform their child (Nachtigall et al 1997; Daniels and Thorn 2007; 
Laruelle et al., 2011). 
In several studies, parental values and beliefs guide their decision to 
disclose or not (Brewaeys et al., 1997; Baetens et al., 2000; Hahn and Craft-
Rosenberg, 2002; Murray and Golombok 2003; Golombok et al., 2004; 
Greenfeld and Klock, 2004; Lalos et al., 2007; Daniels and Thorn, 2007; 
Daniels et al., 2011; Isaksson et al., 2011; Yee et al., 2011). Those who intend 
to disclose or have done so already, reported that it is the child’s right to 
know, they value the principle of honesty in building the parent-child 
relationship, they think that not knowing would be harmful for the child’s 
self-esteem and create shame. Furthermore, they think it may be difficult to 
maintain secrecy and to avoid accidental disclosure. Non-disclosers want to 
protect the child from the risk that information might have a harmful effect 
on family functioning, or they do not see any benefit in telling, and want to 
maintain their right for privacy. 
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Disagreement of the disclosure issues within the couple can lead to conflict 
and delayed decision-making (Daniels et al., 1995; Shehab et al., 2008). The 
highest level of agreement was found among disclosing parents (Readings et 
al., 2011). A 14-year follow-up study showed that once the decision was 
made, it was maintained over the years (Daniels et al., 2009). 
Research has revealed higher rates of disclosure to offspring among OD 
parents compared to those conceived using donor sperm (Klock and 
Greenfeld, 2004, Murray et al., 2006; van den Akker, 2006; van Berkel et al., 
2007). The possible explanation for this is that after OD treatment, 
pregnancy and delivery compensate for the absence of a genetic link between 
mother and child (Greenfeld et al., 1998). Men are generally less likely to talk 
about their infertility and men who need donor sperm are more secretive and 
thus more often choose non-disclosure compared with OD recipients 
(Isaksson et al., 2011). 
Recipient couples who have more information about the donor might 
more often share the information with offspring about his/her genetic origin 
(Cook et al., 1995). Parents may be worried that lack of information could be 
harmful for the development of the child (Cook et al., 1995; Brewaeys et al., 
1997; Lycett et al., 2005). Some parents-to-be might not always wish to have 
information about the donor and therefore choose an anonymous donor 
(Golombok et al., 2004) and those who have already decided to disclose, are 
in favour of an open identity donor (Brewaeys et al., 1997, 2005). 
One of the main concerns in the disclosure decision process has been at 
which age to share the information with the child. Parent’s view on an 
appropriate age to disclose has been 7-11 years (Readings et al., 2011). There 
is an advantage in disclosing early because then they have “always known” 
and they respond neutrally and with curiosity (Scheib et al., 2005; Blake et 
al., 2010). Late disclosure during adolescence or adulthood might raise 
negative feelings, distrust, and anger among offspring (Daniels et al., 2005; 
Jadva et al., 2009). 
Several studies have reported that parents have told at least one other 
person about the donor conception although they have decided not to tell the 
child (Baetens et al., 2000; Gottlieb et al., 2000; Murray and Golombok, 
2003; Klock and Greenfeld, 2004; Lycett et al., 2005). Family support is 
regarded to be important and it is easier to inform the child when family 
members are informed about the way of conception (Shehab et al., 2008). 
However, other studies reported that parents were not influenced by their 
families (Hahn and Craft-Rosenberg, 2002). Reasons for not telling other 
people were to protect the offspring from being treated differently or need for 
privacy. Reasons for telling were wanting to be honest, to discuss 
psychological issues, and looking for support (Baetens et al., 2000; Blyth et 
al., 2010). Maternal family members were more likely to know about the 
donor treatment than paternal (MacCallum and Golombok, 2007). 
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2.10.2. PARENTAL DISCLOSURE INTENTIONS AND REALITY 
 
Studies of parental decisions regarding information sharing with offspring 
have mainly been based on one time point. Follow up studies of parental 
decision-making are scarce. Studies from the 1990’s showed that only 0–3% 
of parents who conceived with donor sperm, had told the child aged 5–6 
years and 75% had decided not to tell (Golombok et al., 1996; Brewayes et al., 
1997). Later, research showed that parents started to be more open, and 11–
15% had told the child by the age of 15 (Gottlieb et al., 2000; Lycett et al., 
2005; Isaksson et al, 2012). Reports from USA and New Zealand showed that 
32–35% of parents of AID offspring had told their child (MacDougall et al., 
2007; Daniels et al., 2009). In the follow-up study 14 years apart, where 
parents had decided to tell or not, none had changed their minds. In 
situations with disagreement between partners or uncertainness regarding 
what to do, the majority favoured not telling (Daniels et al., 2009). 
According to a review article, oocyte recipient couples (26–70%) are 
more open about the donor conception than sperm recipient couples (10–
35%) (van den Akker, 2006). In a Finnish study from 1998, 38% of OD 
parents intended to disclose the way of conception to their child 
(Söderström-Anttila et al., 1998). There are conflicting findings regarding 
disclosure when the donor has been known to the recipient couple. Some 
studies showed preference for disclosure (Baetens et al., 2000; Yee et al., 
2007) while others reported opposite views (Klock and Greenfeld et al., 
2004; Laruelle et al., 2011). 
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Table 1 Studies examining parental disclosure decision after donor insemination (DI) and oocyte 
donation (OD) 
Reference Sample  DI/ 
OD 
Children’s  
age 
Told (%) Plan to tell  
(%) 
Uncertain  
(%) 
Plan not to  
tell (%) 
Golombok et al.  
(1996) 
111 mothers DI 4–8 0 12 13 75 
Rumball and 
Adair (1999) 
78 couples 
23 mothers 
2 fathers 
DI 1–8 30 54 4 12 
Gottlieb et al.  
(2000) 
122 couples DI 1–15 13 51 13 23 
Golombok et al.  
(2002) 
94 mothers DI 11–12 8 10 12 70 
Murray et 
Golombok  
(2003) 
17 couples OD 3–-8 0 29 24 47 
Scheib et al.  
(2003) 
45 couples DI 12–17 93 4.5 2.5 0 
Klock and 
Greenfeld  
(2004) 
62 mothers 
62 fathers 
OD 0–8 11 
8 
48 
45 
7 
6 
34 
41 
Lycett et al.  
(2005) 
46 couples DI 4–8 13 26 17 44 
Golombok et al.  
(2006) 
41 mothers 
41 mothers 
DI 
OD 
3 5 
7 
39 
61 
10 
10 
46 
22 
Lalos et al.  
(2007) 
19 mothers 
17 fathers 
DI 
DI 
1–15 58 
64 
26 
18 
0 
0 
16 
18 
MacDougall  
et al. (2007) 
62 couples 
79 couples 
DI 
OD 
1–19 32 
23 
45 
58 
6 
9 
16 
10 
Readings et al.  
(2011) 
36 couples 
32 couples 
DI 
OD 
7 28 
41 
19 
31 
14 
12 
39 
16 
Isaksson et al. 
(2012) 
55 mothers 
48 fathers 
59 mothers 
53 fathers 
OD 
OD 
DI 
DI 
1–4 18 
13 
17 
17 
75 
77 
80 
79 
5 
8 
0 
2 
2 
2 
3 
2 
Blyth et al.  
(2013) 
94 couples OD 1–15 51 42 4 3 
Applegarth  
et al. (2016) 
46 couples OD 7–19 43 39 9 9 
39 
 
2.10.3. DONORS’ PERSPECTIVE 
Nowadays, when open-identity donation has been more common, donor’s 
attitudes and interests in their donor offspring, have become an important 
issue. Donor legislation in many countries allows release of identifying 
information of the donor for the child at a certain age, but it does not 
guarantee that parents inform the child about his/her genetic origin. Among 
parents, future contact with the donor may be seen as a threat to the non-
genetic parent (Isaksson et al., 2011). 
There appears to be positive attitudes towards disclosure among oocyte 
donors that are reflected in their willingness to take part as identifiable 
donors (Purewal and van den Akker, 2009). A significant majority of 
volunteer oocyte donors would want the offspring to know how they were 
conceived (Söderström-Anttila, 1995; Jadva et al., 2011; Lampic et al., 2014). 
Mostly, no differences have been reported in donor opinions of disclosure if 
they donated to a known recipient or anonymously (Baetens et al., 2000). In 
one study of known oocyte donors, 69% wanted that the nature of conception 
should be told to the child (Yee et al., 2007). More information is needed on 
open-identity donors’ attitudes towards disclosure and offspring. A Swedish 
study included 125 egg donors and 80 sperm donors under an open-identity 
system, and they found that 71–91% of all donors wanted that parents would 
tell the donor offspring about the way of conception and 80–87% had 
positive or neutral attitudes regarding contact with the child in the future 
(Lampic et al., 2014). 
A systematic review of sperm donors’ attitudes towards anonymity found 
conflicting results (van den Broeck et al., 2013). Only four out of 20 studies 
included in the meta-analyses asked the donors about the disclosure issue. 
These studies reported that 30–50% of sperm donors think that parents 
should tell the child of its conception (Daniels et al., 1996, 2005). Of 
anonymous sperm donors, 43% wished that offspring had been told and 
some donors would have been ready to be identifiable later (Daniels and 
Thorn, 2008). In the 1990’s, the majority of donors favoured being 
anonymous, but attitudes have changed during the last decades (Daniels et 
al., 2005; Jadva et al., 2011). 
2.10.4. CHILDREN’S WELL-BEING AND DISCLOSURE 
Information on issues concerning children’s well-being after donor 
treatment, is of utmost importance. Arguments in favour of disclosure are 
that not informing the child of his/her origins violates a child’s autonomy 
(McGee et al., 2001) and human beings have interest in knowing their 
biological origins (Frith, 2001; Daniels, 1995; Hahn and Craft-Rosenberg, 
2002). Research has shown that families who have disclosed indicates no 
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harm for the child and suggests a positive effect on parent-child relationship 
(Lycett et al., 2004; Scheib et al., 2005; Golombok et al., 2011). Other 
concerns relate to the timing of information sharing with the offspring. No 
research identifies a specific ideal age for telling the child, because no 
association between disclosure and family or offspring functioning has been 
demonstrated (Jadva et al., 2009; Mahlstedt et al., 2010). In contrast, some 
studies have found that early disclosure is associated with higher levels of 
psychological well-being among donor offspring (Jadva et al., 2009; Ilioi et 
al., 2016). 
Those who argue against disclosure want to normalise their families, they 
want to be seen as real parents and minimise the donor’s role. Children who 
have been told do well psychologically but, on the other hand, no harm has 
been reported by nondisclosure (Golombok et al., 2002; Readings et al., 
2011; Pennings, 2017). Kovacs et al. (2015) and Ilioi et al. (2016) looked at 
family functioning, mother-child relationship, and adolescent psychological 
adjustment between non-disclosing, disclosing, and natural conception 
families and found no significant differences regarding child well-being. 
Some studies have looked into the experiences of children who have 
found out that they were conceived with donor gametes. Youths (12-17 years) 
who were conceived with open-identity donor sperm, were asked how they 
felt about it. The majority of the respondents felt comfortable with their 
donor gamete origins and planned to obtain donor’s identity when allowed. 
Most of them (76%) had always known (Scheib et al., 2005). Zadeh et al. 
(2018) reported similar results among sperm and OD offspring aged 14 years. 
Two internet-based studies found that offspring who were informed about 
their conception as adults felt mistrust, lack of genetic continuity, and 
frustration. Furthermore, they thought that an earlier disclosure would have 
been a more positive experience. One third wanted more than non-
identifying information about the donor (Turner and Coyle, 2000). In an 
Australian study which examined the relationship of genes and the meaning 
of family, donor offspring felt that they have the right to learn about their 
donor origin. These persons thought that they themselves could consider 
becoming gamete donors if they had a possibility to develop a relationship 
with the offspring (Kirkman, 2003). Finally, adult AID offspring were asked 
about their opinions of donor treatments generally. They felt that there is no 
need for secrecy in donor conception and they would have wanted parents to 
use donors with identifying information (Mahlstedt et al., 2010). Beeson et 
al. (2011) found similar results as offspring had a wish for greater openness 
and contact with the donor. 
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2.11. COUNSELLING 
One of the first reports about a role for mental health professionals in an 
infertility treatment program was published in 1984 (Greenfeld et al., 1984). 
Since then, the involvement of mental health professionals in counselling has 
grown because the number of unconventional ART treatments are 
increasing, and patients may benefit from psychological counselling (Practice 
committee of ASRM, Recommendations of gamete and embryo donation, 
2013). Pretreatment counselling in connection to donor gamete treatments 
has become a central recommendation in guidelines in many countries. 
However, the practice varies, in some countries it is legislated and in some it 
is minimal (Blyth, 2012). In Finland, pretreatment counselling for gamete 
recipient couples became mandatory in 2007. 
Donor gamete recipients have found counselling useful and they have 
positive attitudes about the experience (Hershberger et al., 2007; 
Hammarberg et al., 2008; Shehab et al., 2008). Counselling has often 
focused on the issues of how to inform the child about his/her genetic origin. 
From the patients’ perspective, mental health professionals should be neutral 
in their beliefs and values when talking about disclosure issues (Hershberger 
et al., 2007; Shehab et al., 2008). There is no evidence that parents will 
follow mental health professionals’ recommendations (Daniels et al., 2009). 
Other goals for counselling include: to provide realistic information about 
having a child after donor conception treatment; to explore possible fears; 
and to talk about the previous losses during the long infertility treatments 
and loss of genetic tie with the child. Regardless of disclosure, parents should 
leave a session with less fear of the unknown (Benward, 2015). 
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3. AIMS OF THE STUDY 
The purpose of the study was to examine psychological issues relating to 
what parents face after successful fertility treatment with donated gametes. 
Specifically, the aims of this study are: 
 
1. assess the level of fear of childbirth and pregnancy-related anxiety 
in oocyte recipients in comparison with women conceiving with 
conventional IVF or spontaneously. 
2. examine whether the experience of childbirth differs between 
women conceiving with donor oocytes and those who are pregnant 
after IVF/ICSI or spontaneously. 
3. clarify whether mental health of mothers and fathers after 
successful donated-oocyte treatment differs from that of mothers 
and fathers conceiving with IVF/ICSI as well as spontaneously. 
4. collect information about parental disclosure intentions regarding 
informing their children about their way of conception after donor 
insemination, donor IVF, and donor-oocyte fertility treatment 
before the Finnish ART law enacted in 2007. 
5. obtain information about parental attitudes and satisfaction 
regarding the treatment decision, counselling, and feelings towards 
the child. 
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4. SUBJECTS AND METHODS 
At the time of the study, evaluation of the recipient couple was similar to that 
of couples undergoing conventional IVF treatment with autologous oocytes. 
High-risk recipients with medical conditions that may affect pregnancy or 
women of advanced age were referred to a pre-pregnancy health 
consultation. Counselling with a therapist or psychologist was highly 
recommended, but not mandatory before the ART law in 2007. 
Oocyte and sperm donors were either anonymous or known (e.g. a sister 
or a friend) to the recipient couple. Evaluation of the donor candidates was 
done according to Väestöliitto fertility clinic`s practices. 
4.1. STUDY DESIGN 
Table 2. Study design according to the original publications 
Study I II III IV 
Setting Prospective, 
controlled 
Prospective, 
controlled 
Retrospective Retrospective 
Data source Medical records, 
questionnaire 
Medical records, 
questionnaire 
Questionnaire Questionnaire 
Times of data 
collection 
2nd trimester of 
pregnancy, 8 
weeks after 
delivery 
2nd trimester of 
pregnancy, 8 
weeks and 1 
year after the 
delivery 
1–14 years after 
delivery 
1–22 years after 
delivery 
Main study 
questions 
Compare levels 
of fear of 
childbirth, 
pregnancy-
related anxiety 
and delivery 
experience 
among mothers 
after OD, 
IVF/ICSI and 
spontaneous 
conception 
Compare 
mental health 
symptoms 
between 
mothers and 
fathers after 
OD, IVF/ICSI 
and 
spontaneous 
conception 
Issues 
concerning 
parental 
disclosure of 
OD: intentions 
vs reality 
Issues 
concerning 
parental 
disclosure of 
sperm donation: 
intentions vs 
reality  
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4.2. SUBJECTS 
4.2.1. STUDIES I-II 
 
The study group comprised 26 couples who conceived with donated oocytes 
and their matched controls: 52 women who conceived with IVF/ICSI with 
own gametes and 52 women who conceived spontaneously (SC). The OD 
study group represented 69% of all OD mothers who became pregnant in the 
recruiting clinics in 1999. These two studies are part of larger prospective, 
controlled, longitudinal follow-up study of focusing on psychological health 
of couples after successful IVF/ICSI treatment. The original IVF/ICSI group 
was comprised of 460 couples who were recruited from five fertility clinics in 
Finland (Väestöliitto Fertility clinics in Helsinki, Turku and Oulu, the 
Deaconess Institute of Helsinki and the University Hospital Helsinki) on a 
voluntary basis. Spontaneously conceiving controls (497 couples) were 
recruited when attending routine second-trimester ultrasounds in Helsinki 
University Hospital. They reported no history of infertility, they were Finnish 
speaking, over 25 years of age, and took part in of the study voluntarily. 
The full response rate of OD mothers (T1-T3) was 76.9%. Among OD 
fathers, the response rate was 73.1%, among IVF/ICSI fathers it was 75.1% 
and 67.3% among SC fathers (ns). Matching was performed to find IVF/ICSI 
and SC controls according to mothers age (<34, 35-37, >38), parity 
(primipara or multipara), plurality (singleton or twin pregnancy), and 
number of returned questionnaires. Background information of the 
participants and their controls is presented in Table 3. Fertility history did 
not differ between OD and IVF/ICSI couples regarding duration of infertility: 
it was 5.9 years among OD couples and 5.1 years among IVF/ICSI couples (F 
= 0.929; p = 0.339). Number of fertility treatments received before 
successful pregnancy was similar between OD and IVF/ICSI couples (mean 
3.1 vs 2.9; F = 0.379; p = 0.540). Only the reasons for infertility differed (X2 
= 17.51; p = 0.001). For the OD couples the most common reason for 
treatment was premature ovarian insufficiency (15/26), whereas in the 
IVF/ICSI couples it was unexplained infertility. 
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Table 3 Demographic characteristics of oocyte donation (OD), IVF/ICSI and spontaneously 
conceiving (SC) groups 
 OD, n = 26 IVF/ICSI, n = 52 SC, n = 52 
Maternal age, mean (SD) 36.1(6.1) 35.2(4.5) 35.1(4.3) 
Paternal age, mean (SD) 37.6(6.3) 35.6(4.7) 35.2(5.4) 
Occupation, mothers, n (%)    
High professional 8(30.8) 18(35.3) 26(50.0) 
Low professional 6(23.1) 19(37.3) 17(32.7) 
Skilled worker 10(38.5) 9(17.6) 5(9.6) 
Unskilled worker 2(7.7) 5(9.8) 4(7.7) 
Occupation fathers, n (%)    
High professional 6(25.0) 18(40.0) 22(50) 
Low professional  7(29.2) 14(31.1) 9(20.5) 
Skilled worker 9(37.5) 10(22.2) 8(18.2) 
Unskilled worker 2(8.3) 3(6.7) 5(11.4) 
Marital status, n (%)    
Married 18(69.2) 36(76.6) 28(60.9) 
Cohabiting 8(30.8) 11(23.4) 17(37.0) 
Separated 0 0 1(2.2) 
Duration of partnership, years mean 8.7(5.3) 9.3(4.9) 6.9(4.9) 
 
4.2.2. STUDY III 
During 1992-2006, altogether 175 couples had been treated with OD at 
Väestöliitto Fertility clinic in Helsinki. Information on the OD study group, 
reasons for exclusion and response rate is shown in Figure 5. 
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Figure 5. Formation of OD study group 
 
The response rate did not differ among parents with different ages of 
children. A majority of the couples (85%) had received donated oocytes from 
an anonymous donor and 15% had a known donor (sister, niece, sister-in-
law, cousin, friends, and donor through newspaper advertisement). The 
indication of OD treatment was POI in 45% of women. Of the responding 
couples, 55% had tried to conceive spontaneously or using ART with 
autologous oocytes for 1-20 years (mean 5.6 years). 
Of all responding parents, 40/167 had two OD children, 13 had three OD 
children, and 13 had children born with own gametes in addition to OD 
offspring. 
 
4.2.3. STUDY IV 
 
During 15 years (from 1992 to 2007), 277 heterosexual couples had a child 
after successful treatment with donor insemination (DI) or donor IVF 
treatment (dIVF) at Väestöliitto Fertility clinic in Helsinki. A questionnaire 
was sent to 252 mothers and 239 fathers with donor-sperm offspring (Figure 
6). Reasons for exclusion and the response rates are shown in Figure 6. 
 
 
175 OD couples
received  treatment
in 1992-2006
Refused contact 1
Language problem 1
Parental death 4
Address not confirmed 7
Perinatal death 1
Questionnaires sent to
167 mothers
163 fathers
They had
231 children
Response rate
Mothers 113/167 (68%)
Fathers 100/163 (61%)
Provided information on
Children 164/231 (71%)
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Figure 6. Formation of DI/dIVF study group 
 
Answers provided information on 57.8% (240/415) of the children born. 
Siblings born before 1992, were also included in the study. The proportion of 
twin pregnancies was 9.6%. 
Of the parents, 41 had two children born with DI or dIVF, 10 had three or 
more children, and 18 had children born with own gametes in addition to the 
donor offspring and one couple had one adopted child in addition to donor 
offspring. Only one couple had a known donor. 
 
4.3. METHODS 
4.3.1. STUDIES I-II 
The participants completed the questionnaire during gestational weeks 18-20 
(T1), 8 weeks after delivery (T2), and when the child was one year old (T3). 
Mothers and fathers were asked to fill in questionnaires separately. 
Background information about occupation, marital status, infertility history, 
and early pregnancy were collected from medical records by the person who 
recruited the couple to take part in the study at the time of ultrasound in 
early pregnancy or routine 2nd trimester ultrasound. 
The first questionnaire was given when the couples were recruited for the 
study in 2nd trimester. Questions included information on social background, 
lifestyles, general health, and somatic problems in early pregnancy. The 
second questionnaire was sent to the couple after the delivery and after they 
277 DI/dIVF couples
received  treatment
in 1992-2007
Refused contact 3
Language problem 1
Parental death 9
Address not confirmed 22
Questionnaires sent to
252 mothers
239 fathers
They had
415 children
Response rate
Mothers 139/252 (55%)
Fathers 127/239 (53%)
Provided information on
Children 240/415 (58%)
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were first contacted by the research nurse. In the second questionnaire 
mothers were asked to report any pregnancy complications (pre-eclampsia, 
hypertension, vaginal bleeding, preterm contractions, and cholestasis in 
pregnancy) and related hospitalisation after 20 pregnancy weeks. 
Information on onset of labour and the type of delivery (vaginal, vacuum, 
Caesarean section) were collected with multiple-choice questions. The 
information about the health of newborns was gathered with questions 
concerning gestational age at birth, birth weight and height, general health, 
admission to neonatal intensive care unit (NICU) and length of stay there. To 
obtain information on maternal psychological and physical health after the 
delivery, hospitalisation time and reason was recorded. Structured 
questionnaires were used to assess the mental health of mothers and fathers 
(T1-T3), fear of childbirth and pregnancy-related anxiety (T1-T2), and 
experience of delivery (T2). 
4.3.1.1. Fear of Delivery Questionnaire (FDQ) 
The revised version by Saisto (Saisto et al., 2001) comprises 11 dichotomous 
questions of pain, losing control, isolation, and giving birth to an unhealthy 
child. The participants evaluated their feelings on a two-point scale (0= no; 1 
= yes). A sum variable in which higher score indicates stronger fear, was 
constructed. The reliability was 0.68 (Cronbach α). Request of caesarean and 
higher score than 5 indicated severe fear. FDQ was to be filled in at T1. 
(Study I) 
4.3.1.2. Pregnancy Anxiety Scale (PAS) 
The revised scale by Levin (1991), consists of 10 questions about anxiety in 
pregnancy, childbirth, and hospitalisation. This is a five-point scale (1 = not 
at all, 5 = a lot) giving a possible range of sum score from 10 to 50. Higher 
sum scores indicated greater anxiety. The reliability was 0.82 (Cronbach α). 
Pregnancy-related anxiety was assessed with PAS at T1 and T2 to assess level 
of anxiety about future pregnancies. (Study I) 
4.3.1.3. Delivery Satisfaction Scale (DSS) 
DSS served to assess experience of childbirth at T2. It comprises eight 
questions, of them six focuses on delivery experience and two on labour pain. 
They answered on a 5-point scale (1 = not at all, 5 = very much). Sum score was 
constructed and a total score in or below the 10th percentile indicated 
dissatisfaction with the delivery. The reliability was 0.72 (Cronbach α) (Study I). 
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4.3.1.4. General Health Questionnaire 36 (GHQ-36) 
Mental health problems were assessed using the General Health 
Questionnaire at T1, T2, and T3. Both parents answered separately. This is a 
self-report questionnaire designed to measure psychiatric disorders in the 
general population. It performs well as a screening instrument and has 
proven to function well in the population in Finland (Rantakallio, 1988; Holi 
et al., 2003). It consists of 36 items that measure depression (11 items), 
anxiety (11 items), social dysfunction (8 items) and sleeping difficulties (6 
items). Depression involves feelings of hopelessness and suicidal thoughts, 
anxiety involves feeling of being under constant pressure and panicked, 
sleeping involves difficulties in falling asleep and waking up in the night and 
social dysfunction involves the inability to perform everyday tasks and 
participating in social activities. Respondents estimated how symptoms 
matched their current state from 1 (=not at all) to 4 (=much more) than 
usual. Sum scores were calculated for each symptom to make subscale scores 
comparable. Dichotomic variables of mental health clinical significance were 
(original values 1-2=0 and original values 3-4=1) created. Total score GHQ 
36 cut-off point 9 and above was the criterion for clinical significance for 
mental health symptoms based on Finnish samples (Holi et al., 2003). 
 
Table 4. Methods used to collect data in studies I and II. 
 Study I Study II 
T1: 2nd trimester of 
pregnancy 
SES. Family factors: age, 
number of children, duration 
of partnership, marital 
status. FDQ. PAS.  
SES. Family factors: age, 
number of children, duration 
of partnership, marital 
status. GHQ 36 (mothers and 
fathers) 
T2: 8 weeks postpartum Pregnancy complications and 
related hospitalisation. Mode 
of the delivery. Gestational 
age. Health of the newborn. 
PAS. DSS.  
Pregnancy and postpartum 
complications and 
hospitalisation. GHQ 36 
(mothers and fathers) 
T3: 1 year postpartum - GHQ 36 (mothers and 
fathers) 
SES= Socioeconomic status; FDQ= Fear of Childbirth Questionnaire; PAS= Pregnancy 
Anxiety Scale; DSS= Delivery Satisfaction Scale; GHQ-36= General Health Questionnaire 36 
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4.3.2. STUDIES III-IV 
Studies were carried out by means of questionnaires, which were sent to 
couples who were treated with OD or sperm donation at the Väestöliitto 
Fertility clinic in Helsinki between 1992–2006. Information on infertility 
factors and type of treatment were collected from the patient registries as 
well as data on early pregnancy and the result of pregnancy. Parental 
background information, such as age, marital status, education, and the 
indication for the treatment was collected in the first part of the 
questionnaire. The parents were asked in structured questions if they had 
told (1 = yes; 2 = no) or planned to tell (1 = not told yet but intend to tell; 2 = 
not told yet, don’t intend to tell; 3 = don’t know) their child about the way of 
conception and if they had told, at which age they had done so. There were 
multiple choice questions about the importance of information sharing with 
their child (it is natural to be open and honest, the child has right to know, to 
avoid accidental disclosure from others, another reason), and which reasons 
are not important (information is unnecessary, it could be harmful for the 
child, concern that the child would attach to the donor, another reason). 
Then there were questions about openness toward other people (1 = nobody; 
2 = closest family members; 3 = closest friends; 4 = openly). 
Parents were asked about the decision process to use donated gametes 
and if they felt that the child was their very own. Parents were asked to report 
their concerns about the donor characteristics, such as genetic and medical 
background, physical resemblance, personality, intelligence, and whether 
they had worries that their child would fall in love with his/her half sibling. 
There were questions about parents’ satisfaction with the counselling they 
received before treatment, whether it was sufficient or not. In addition, open 
questions were included regarding wishes for a psychological support. 
Parents could express their opinions about the new fertility law in Finland 
and about patient support groups. Finally, they were asked to give any 
information about the child’s health problems diagnosed. 
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5. STATISTICAL ANALYSIS 
Statistical analyses were performed using SPSS-17-24 (IBM corp., Armonk, 
NY, USA). Categorical variables were analysed by means of X² tests and 
continuous variables by means of Student’s t-tests in studies III and IV. P 
values less than 0.05 were considered significant. 
Group differences of FDQ, PAS, and DSS were analysed by means of analysis 
of variance ANOVA with the post- hoc test and Tukey’s correction were used 
to analyze differences between OD, IVF/ICSI and SC (study I). Spearman’s 
correlation coefficients were used to analyze relations between fear of 
childbirth and pregnancy – related anxiety as well as satisfaction with the 
delivery (study I). A p value < 0.05 was considered significant. 
In study I and II, chi-squared test was used to analyze group differences 
in the categorical data (demographic data, infertility and obstetric 
information) and analysis of variance with Bonferroni corrected post-hoc test 
in the continuous data (age, duration of partnership, days of hospitalisation). 
If the chi-squared test was positive, the specific within-group differences 
were calculated by adjusted residual values of each cell, using the criterion of 
> 2.00 of z-values (p < 0.05). Differences in parental mental health problems 
in OD, IVF/ICSI and spontaneous pregnancy groups were analysed by 
covariate analyses with univariate analyses with Bonferroni corrected post-
hoc tests (study II). The covariates were the frequency of hospitalisation at 
second and third trimesters (0 = no, 1 = yes) and length of hospitalisation 
postpartum. 
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6. RESULTS 
6.1. FEAR OF CHILDBIRTH AND DELIVERY 
EXPERIENCE (I) 
 
The number of treatments performed before the pregnancy (OD 3.1 vs 
IVF/ICSI 2.9) did not differ between the OD and the IVF/ICSI groups. 
Among those women having undergone OD treatment, 65.3% became 
pregnant after one or two ETs with donated oocytes. Naturally, reasons for 
infertility treatments differed (χ² = 17.51; p = 0.001). In the OD group the 
most common indication treatment was POI, and in the IVF/ICSI group it 
was unexplained infertility. 
The obstetric outcome is shown in Table 5. Length of gestation, preterm 
deliveries, birthweight, and separation at birth (NICU) did not differ between 
the groups. 
 
Table 5. Obstetric factors of oocyte donation (OD), IVF/ICSI, and spontaneously conceiving (SC) 
groups. Matched to parity and type of pregnancy. 
 OD, n=26 
(%) 
IVF/ICSI, n=52 
(%) 
SC, n=52 
(%) 
Parity    
Primipara 16(61.5)   
Multipara 10(38.5)   
Type of pregnancy    
Singleton 21(80.8)   
Twin 5(19.2)   
Hospitalisation in 1st trimester (%) 1(3.8) 2(4.5) 2(4.2) 
Hospitalisation in 2nd and 3rd 
trimester (%) ∗ 
8(32) 13(26.5) 5(10.0) 
Mode of the delivery (%)    
Vaginal, spontaneous 14(53.8) 26(51.0) 29(55.8) 
Acute operative (vacuum, caesarean) 6(23.1) 15(29.4) 16(30.8) 
Elective caesarean 6(23.1) 10(19.6) 7(13.5) 
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Pain relief    
None 3(12.5) 0(0) 3(6.3) 
Epidural 14(58.3) 35(76.1) 37(77.1) 
Other  7(29.2) 11(23.9) 8(16.7) 
Premature delivery <37 weeks 5(19.2) 4(7.8) 9(17.3) 
Separation at birth 12(50) 13(25) 17(32.7) 
 mean (SD) mean (SD) mean (SD) 
Birthweight, grams 3321(786) 3298 (699) 3368 (641) 
Hospitalisation, postpartum, days, 
mean (SD) ∗ 
5.3(1.9) 4.2(2.1) 3.8(1.6) 
*p < 0.05 
6.1.1. GROUP DIFFERENCES IN FEAR OF CHILDBIRTH 
The groups differed in their levels of fear of childbirth (ANOVA, F (2,114) = 
3.692; p = 0.028). Mean total score Fear of Delivery Questionnaire (FDQ) 
was lower in OD group than in IVF/ICSI group (OD 1.5, IVF/ICSI 2.9, SC, 
2.5; p = 0.021) but SC group did not differ significantly from either. For 
severe fear of childbirth (FDQ >5), there was no significant differences 
between the groups (OD 4.2%, IVF/ICSI 15.9%, SC 19.1%; X² = 2.903, p = 
0.234). Fewer OD women (12%) asked for caesarean compared with the 
IVF/ICSI (15.9%) and SC (30%) women, but the difference was not 
statistically significant (X² = 4.348; p = 0.114). 
6.1.2. GROUP DIFFERENCES IN PREGNANCY ANXIETY 
The groups differed in severity of pregnancy-related anxiety (ANOVA, F(2, 
116) = 5.25 ; p = 0.007). Post hoc analysis revealed that mean total score 
Pregnancy Anxiety Scale was lower in the OD group (17) than in the IVF/ICSI 
group (22.1, p = 0.006) and in the SC group (21.4, p = 0.019). OD women 
experienced lower levels of anxiety about all parameters but statistically 
significant differences were reached in lower concerns that the personnel 
might be unfriendly in the hospital (ANOVA, F(2, 121) = 4.17 ; p = 0.018), 
that their child may not be healthy (ANOVA, F(2, 120) = 4.36 ; p = 0.015) 
and about pain during childbirth (ANOVA, F(2, 120) = 3.29 ; p = 0.040). 
Pregnancy Anxiety scale was to be answered again postpartum to measure 
thoughts concerning future pregnancies. It did not reveal any other 
differences between the groups but the OD women’s need for analgesia in 
future deliveries was lower (ANOVA, F(2, 120) = 3.99 ; p = 0.021). 
54 
Correlation between FDQ and PAS in T1 was significant in OD (r = 0.689; 
p = 0.000), IVF/ICSI (r = 0.735 ; p = 0.000) and SC (r = 0.784 ; p = 0.000) 
groups. 
 
Table 6. Mean total scores of Fear of delivery questionnaire (FDQ) and Pregnancy-related 
Anxiety (PAS) among oocyte donation (OD), IVF/ICSI conceived, and spontaneously conceived 
(SC) mothers. 
 OD IVF/ICSI SC F-
values 
Sig.  Pairvise 
comparison 
Mean 
total score 
FDQ 
(SD)  
1.5 (1.3) 2.9 (2.3) 2.5 (2.2) 3.692 0.028 OD<IVF/ICSI, 
p=0.021; 
OD<SC 
p=0.145 
Mean 
total score 
of PAS 
(SD) 
17.0(4.0) 22.1(7.0) 21.4(6.7) 5.257 0.007 OD<IVF/ICSI, 
p=0.006;  
OD<SC, 
p=0.019 
 
6.1.3. GROUP DIFFERENCES IN EXPERIENCE OF CHILDBIRTH 
Satisfaction with deliveries was similar in all three groups. Of OD women 
8.7%, 4.9% of IVF/ICSI women, and 15.6% of SC women (X² = 14.929; p = 
0.135) were dissatisfied with their delivery. Summed scores of Delivery 
Satisfaction Scale was 30 in OD and IVF/ICSI groups and 29 in SC group. 
The mode of the delivery associated with satisfaction of delivery only in the 
OD group. Those mothers who delivered with acute caesarean or vacuum 
were more dissatisfied (ANOVA, F(2, 22) = 17.21 ; p = 0.000). In all three 
groups, there was a correlation between strong pain experienced during the 
delivery and dissatisfaction of delivery [OD (r = 0.735, p = 0.000); IVF/ICSI 
(r = 0.627, p = 0.000); SC (r = 0.618, p = 0.000)]. 
There was a statistically significant correlation between fear of delivery 
and satisfaction with delivery in OD and IVF/ICSI groups showing that 
women fearing delivery were less satisfied with the delivery (OD r = -
0.548, p = 0.010; IVF/ICSI r = -0.404, p = 0.018). The incidence of 
fathers being present during delivery was 91% for OD, 93% for IVF/ICSI, 
and 93% for SC. The women in OD and IVF/ICSI groups were more 
satisfied with the support from their spouses than women in the SC group 
(ANOVA, F(2, 120) = 3.24 , p = 0.042). 
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6.2. MENTAL HEALTH OF MOTHERS AFTER OD (II) 
6.2.1. MENTAL HEALTH OF MOTHERS 
 
Multivariate covariate analysis results showed significant group differences 
at 8 weeks (T2; p = 0.019) and one year (T3; p = 0.027) after the delivery but 
not in the 2nd trimester of pregnancy. 
At T2, OD women reported lower levels of anxiety symptoms (p = 0.01), 
sleeping difficulties (p = 0.04) and social dysfunction (p = 0.001) than 
spontaneously conceiving mothers and lower levels of sleeping difficulties (p 
= 0.02) and social dysfunction (p = 0.04) than IVF/ICSI women. At T3, OD 
women reported lower levels of anxiety than SC women (p = 0.02). 
Furthermore, at T3, OD women had lower levels of sleeping difficulties (p= 
0.04) and social dysfunction (p= 0.03) compared to IVF/ICSI women. 
The groups differed significantly in the frequency of hospitalisation in the 
1st and 2nd trimesters and the length of postpartum hospitalisation. SC 
mothers experienced less hospitalisation due to pregnancy complications 
than OD and IVF/ICSI mothers. OD mothers were hospitalised for longer 
postpartum than SC mothers (5.3 days vs 3.8 days; p = 0.010) but the the 
postpartum stay in hospital was similar to that of IVF/ICSI mothers. The 
length of maternal postpartum hospitalisation as a covariate was 
significantly associated with maternal mental health problems at T2 (p = 
0.034) and at T3 (p = 0.0001). Analysis of variance specified that the longer 
stay at the hospital was associated with higher levels of depressive symptoms 
at T2 (p = 0.004) and with all mental health symptoms in T3 (depressive 
symptoms, p = 0.0001; anxiety, p = 0.009; sleeping difficulties, p = 0.032; 
social dysfunction, p = 0.0001). 
Group differences based on total scores of GHQ-36 showed no differences 
between the OD, IVF/ICSI, and SC mothers at T1 (2nd trimester). At T2, total 
scores were lower among OD mothers than those of IVF/ICSI (p = 0.003) 
and SC mothers (p = 0.03) and at T3, OD mother’s scores were lower than 
those of SC mothers’ (p=0.03). Clinically significant mental health problems 
were low at each time point among OD mothers (T1 = 7.3%; T2 = 5.7%; T3 = 
5.1%) and it differed significantly only compared to SC mothers at T2 (p = 0.04). 
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Table 7. Mental health symptoms measured with General Health Questionnaire 36 (GHQ-36) of 
oocyte donation (OD), IVF/ICSI and spontaneously conceiving (SC) mothers 
 
Mothers OD, n = 26 IVF/ICSI, n 
= 52 
SC, n = 52 F-
valuesa 
Pairwise 
comparisonsb 
 Mean (SD) Mean (SD) Mean (SD)   
T1      
Depression 1.12 (0.17) 1.15 (0.16) 1.19 (0.17) 1.63  
Anxiety 1.33 (0.32) 1.38 (0.34) 1.52 (0.41) 2.12  
Sleeping  1.74 (0.54) 2.07 (0.66) 2.08 (0.73) 2.50  
Social dysf. 1.97 (0.35) 2.09 (0.36) 2.08 (0.46) 0.84  
T2      
Depression 1.16 (0.13) 1.21 (0.32) 1.24 (0.19) 1.92  
Anxiety 1.28 (0.22) 1.50 (0.49) 1.63 (0.56) 4.73** OD<SC* 
Sleeping 1.56 (0.43) 1.94 (0.65) 1.98 (0.63) 6.19** OD<IVF/ICSI, 
SC* 
Social dysf. 1.86 (0.25) 2.11 (0.36) 2.19 (0.40) 7.94*** OD<IVF/ICSI*; 
OD<SC** 
T3      
Depression 1.20 (0.11) 1.28 (0.43) 1.30 (0.26) 1.61  
Anxiety 1.24 (0.19) 1.44 (0.55) 1.56 (0.48) 4.32* OD<SC* 
Sleeping 1.45 (0.35) 1.84 (0.65) 1.84 (0.61) 5.37** OD<IVF/ICSI* 
Social dysf. 1.79 (0.13) 2.03 (0.41) 2.00 (0.36) 5.66** OD<IVF/ICSI* 
 
*p < 0.05, **p < 0.01, ***p < 0.001 
a Covariated for hospitalisation in 2nd and 3rd trimester and days postpartum 
b Post-hoc comparisons 
57 
 
 
6.2.1. MENTAL HEALTH OF FATHERS 
Mental health problems among fathers with an OD child compared to those 
with a child after IVF/ICSI and SC did not differ significantly at any time 
point. The mean total score for GHQ-36 also showed similar levels. Only a 
few fathers with an OD child reported clinically significant mental health 
problems (T1 = 4.2%; T2 = 2.6%; T3 = 5.3%) and these did not differ from 
IVF/ICSI and spontaneously conceived fathers. 
 
Table 8. Mental health symptoms measured with General Health Questionnaire 36 (GHQ-36) of 
oocyte donation (OD), IVF/ICSI and spontaneously conceiving (SC) fathers 
Fathers OD, n = 26 IVF/ICSI,  
n = 52 
SC, n = 52 F-values 
 Mean (SD) Mean (SD) Mean (SD)  
T1     
Depression 1.26 (0.44) 1.24 (0.31) 1.22 (0.19) 0.33 
Anxiety 1.40 (0.41) 1.44 (0.42) 1.37 (0.39) 0.43 
Sleeping  1.65 (0.48) 1.64 (0.57) 1.56 (0.47) 0.75 
Social dysf. 1.85 (0.32) 1.09 (0.38) 1.89 (0.27) 0.04 
T2     
Depression 1.34 (0.44) 1.19 (0.17) 1.23 (0.20) 2.66 
Anxiety 1.43 (0.47) 1.34 (0.33) 1.34 (0.33) 0.96 
Sleeping 1.86 (0.47) 1.59 (0.46) 1.68 (0.53) 2.40 
Social dysf. 1.99 (0.40) 1.91 (0.29) 1.89 (0.30) 0.76 
T3     
Depression 1.41 (0.50) 1.26 (0.17) 1.28 (0.28) 1.50 
Anxiety 1.48 (0.62) 1.33 (0.33) 1.31 (0.36) 1.15 
Sleeping 1.60 (0.48) 1.57 (0.46) 1.64 (0.50) 0.89 
Social dysf. 1.98 (0.46) 1.92 (0.23) 1.95 (0.31) 0.29 
 
58 
6.3. PARENTAL OPENNESS AFTER OD (III) 
6.3.1. DISCLOSURE TO THE CHILD 
Of the mothers, 61% and 60% of fathers reported that they had told their 
child about the way of conception or were planning to do so. There were no 
differences among mothers (60% vs 65%) and among fathers (61% vs 56 %) 
regarding openness if the donor had been anonymous or known, 
respectively. Parent’s education, marital status, indication for treatment, and 
number of genetically own children had no effect on parental openness 
towards the child. Parental disclosure intentions were different in different 
age groups of the children when 88% in younger age group intended to tell 
versus 44% in the oldest age group (p = 0.011). 
Of children aged 3–14, 26% had already received information on their donor 
conception. 
6.3.2. DISCLOSURE TO OTHER PEOPLE 
The majority of mothers (82%) and fathers (71%) had told the medical team 
working in prenatal and postnatal care clinics about the donation treatment. 
Mothers had been more open to other people (closest family members, 
friends) and to medical team compared to fathers (87% vs 71%, p < 0.005). A 
strong correlation was found between the intention to tell the child and 
informing other people (p < 0.005). 
Table 9.  Parents’ reasons to tell or not to tell the child about his/her conception 
 OD mothers  OD fathers  DI/dIVF 
mothers     
DI/dIVF 
fathers  
Reasons to tell 
(answers by those 
who intend to be 
open or unsure) 
(n = 97) (n = 82) (n = 53) (n = 46) 
Natural to be open 
and honest (%) 
66 (68.4) 67 (81.7) 30 (56.6) 27 (58.7) 
Child’s right to know 
(%) 
77 (79.4) 50 (61.0) 30 (56.5) 15 (32.6) 
Risk to avoid 
accidental disclosure 
(%) 
54 (55.7) 36 (43.9) 29 (54.7) 30 (65.2) 
Other (%) 7 (7.2)  3 (5.7)  
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 OD mothers  OD fathers  DI/dIVF 
mothers     
DI/dIVF 
fathers  
Reasons not to 
tell (answers by 
those who are 
inclined to secrecy 
or are unsure) 
(n = 39) (n = 30) (n = 82) (n = 81) 
Information is 
unnecessary (%) 
16 (41.0) 16 (53.3) 27 (32.9) 32 (39.5) 
Information is 
harmful for the child 
(%) 
18 (46.2) 15 (50.0) 25 (30.5) 32 (39.5) 
Concern that the 
child will attach to 
the donor (%) 
4 (10.3) 0 0 0 
Other (%) 10 (25.6) 5 (16.7) 13 (15.9) 10 (12.3) 
 
Other reasons to tell include: secrecy creates tension within the family, to 
prevent possible family conflicts when the child is a teenager, medical 
reasons, to promote identity development 
Other reasons not to tell include: my partner does not want to, will inform 
if forced to because of medical reasons, wish of the known donor, 
unnecessary to tell because the donor was anonymous, risk of inequality 
between the partners, risk that the child would abandon his/her father, 
desire to keep equality between biological children and donor conceived 
child, grandparents would not understand, fear of confusing the child, no 
clear reason, issue is not important for the parents.  
6.3.3. ATTITUDES REGARDING TREATMENT  
Of the mothers, 89% and 81% of fathers reported that the decision to use 
donated oocyte was easy. After the child was born, 100% of mothers and 97% 
of fathers thought it was a right decision to proceed and choose OD. 
Altogether 39% of the mothers and 32% of the fathers had some worries 
about the genetic or medical background of the anonymous donor. Parents 
reported that 13% of OD children had some health problem. The majority of 
the parents had very few or no concerns regarding the donor’s physical 
resemblance, personality, intelligence, or the risk that the child would fall in 
love with his/her half-sibling. None of the 17 mothers with a known donor 
reported any kind of problems in their relationship with the donor. 
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Altogether 59% of the fathers and 54% of the mothers were satisfied with the 
psychological support they were offered during their donor treatment. 
However, 24% of mothers compared with 11% of fathers thought that they 
received insufficient psychological support (p < 0.05). The Finnish ART law 
came into force in 2007 and requires open-identity donation. A total of 31% 
of the mothers and 25% of the fathers thought that the mandatory 
registration of gamete donors was a good decision. Forty percent of the 
parents reported that the law is not going to impact future parents’ disclosure 
intentions. 
 
6.4. PARENTAL OPENNESS AFTER SPERM DONATION 
(IV) 
6.4.1. DISCLOSURE TO THE CHILD 
Of all parents with a child after sperm donation treatment, 41% of mothers 
and 36% of fathers had either told or intended to tell their child. Altogether 
17% of the parents had already told, and 64% of these children were told 
before they started school, at a mean age of 6.8 years. Parents with younger 
children planned more often to inform the child than parents with older 
children (p < 0.005). Parents’ intentions to tell were not dependent on 
education, marital status, or number of children in the family. Of the parents, 
19% had different opinions related to disclosure and in the majority of cases 
(22/27) fathers were more in favour of secrecy. The main reasons to 
inform/not inform the child are presented in Table 9. 
 
6.4.2. DISCLOSURE TO OTHER PEOPLE 
 
Only 5–6 % of the parents had been open to everyone about their child’s 
donor conception background and 38% of mothers and 50% of fathers had 
not told anyone. Parents who had already been or who had decided to be 
open towards the child, were also more inclined to be open towards other 
people (p < 0.005). Mothers had more often than fathers (51% vs 33%; p < 
0.05) informed medical personnel about the nature of conception in prenatal 
and postnatal care clinics. Some mothers (12%) and fathers (5%) regretted 
that they had told other people. They thought afterwards that the child 
should be the first one to know, and they were afraid of accidental disclosure 
from relatives. Furthermore, some parents reported that reactions of 
relatives towards both the child and the father had changed after they were 
told about the donor conception. 
61 
6.4.3. ATTITUDES REGARDING TREATMENT 
 
Similar proportion of mothers (79%) and fathers (70%) thought that the 
decision to use donor sperm in the fertility treatment was easy. Almost all 
mothers (99%) and all fathers (100%) reported that it had been a right 
decision. Of the parents, 92–96 % had very few concerns regarding the 
background (medical or genetic, personality, physical resemblance, 
intelligence) of their anonymous donor. Parents reported that 22% of 
children had some health problem. Of mothers 22% and of fathers 8% 
worried about the risk that the child would fall in love with his/her half-
sibling. 
During the total study period, 39% of mothers and 45% of fathers were 
satisfied with the pretreatment psychological support they were offered (p < 
0.05). However, satisfaction with psychological support and counselling 
increased among parents (38% vs 53%) comparing time periods before and 
after the year 2000. Furthermore, a higher proportion of parents were 
unsure of the usefulness of psychological support before 2000 (33% vs 23%; 
p < 0.05). One out of six parents expressed that they would have wanted 
support during the pregnancy and after the child was born, but such help was 
not easily available. 
Only 24% of mothers and 17% of fathers thought that the removal of 
anonymity in Finland was a good decision. Parents in favour of disclosing 
(29%) thought that the use of open-identity donors is a good practice but 
only 19% of those in favour of non-disclosing thought so (ns). Altogether 46% 
of the mothers and 41% of the fathers reported that the new ART law 
probably will not impact on disclosure intentions of donor offspring parents 
in the future. 
 
 
   
Figure 7. Parental disclosure intentions after oocyte donation (OD) and donor insemination/ 
donor IVF (DI/dIVF) treatments in different age group of donor conceived children. 
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7. DISCUSSION 
 
Sperm donation has been used for over a century, but since IVF technology 
was discovered over 30 years ago, OD treatment has been possible. During 
the last decades, the number of gamete donation treatments has been rising 
worldwide to help couples who could not acheive pregnancy with their own 
oocytes or sperm. Treatments with donated gametes have a high success rate, 
even higher than with autologous gametes, which gives hope and brings great 
joy to the future parents. 
When the use of donated gametes is the only option to overcome the 
infertility, couples face feelings of uncertainty for the future. Questions will 
arise, like “Am I ever going to get pregnant?”, “Is my body able to carry a 
child?”, “Am I able to love my child and does the child feel like own?”, “How 
am I able to tell the child about his/her conception?”, “What will the closest 
relatives and friends think?”, “What if my child wants to contact the donor?”. 
Apart from uncertainty, the parents are also involved with emotional 
loss related to genetic connection with the child. Parental psychological 
well-being is associated with the child’s psychological development. The 
more is known about parental well-being and psychological adjustment 
during the course of donation treatment, the better the parents and donor-
conceived children can be supported. One of the main issues that parents 
have to face after the successful treatment is the question of secrecy about 
the donor conception. 
The data used in studies I and II was collected with longitudinal 
prospective self-reported questionnaires. Three assessment points (2nd 
trimester, 2 months, and 1 year postpartum) were chosen because these 
points represent different phases of family life such as pregnancy, parent-
infant relationship, and child development. IVF/ICSI and spontaneously 
conceiving controls were chosen from a larger cohort. Matching to find 
controls was made according to mother’s age, parity, plurality, and number 
of returned questionnaires to find controls. Instead of using the whole 
cohort, the above criteria were chosen to match the controls, because they 
are all known factors affecting the mental health of parents and maternal fear 
of childbirth, thus eliminating confounding factors in the analyses. 
Background characteristics were similar across the groups. Controls were 
recruited in Helsinki where the education level of mothers is higher 
compared with other parts of Finland where some of the IVF/ICSI controls 
and OD mothers were recruited. However, it was not statistically significant 
between the groups. Previous studies have shown that fear of delivery and 
mental functioning are unaffected by the education level of mothers in the 
Finnish population (Saisto et al., 2001; Poikkeus et al., 2006; Martikainen 
et al., 1999). 
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Unexpectedly, obstetric outcome was similar across the groups. Pregnancy 
complications causes higher levels of pregnancy-related anxiety. Acute 
operative deliveries and pain experienced during labour are associated with 
delivery dissatisfaction. Furthermore, poor child health and worry about the 
infant associates with anxiety and depression among mothers. Therefore, a 
similar obstetric background between the OD group and IVF/ICSI and SC 
groups made the results more reliable. 
Data for studies III and IV was collected by questionnaire in a 
retrospective manner. Questionnaires were sent separately for both partners 
involved. In previous studies, questionnaires and interviews have mostly 
been directed only to mothers. The majority of the questions were multiple 
choice, but there were also open-ended questions which better facilitates the 
collection of detailed information on personal feelings and experiences which 
could have been missed with structured answers. 
There are several strengths of the studies. High reponse rate and fathers’ 
participation are worth mentioning as most of this type of studies are 
directed only to mothers (studies I and II). The fact that mothers and fathers 
gave their answers separately could not be controlled, however. Of all OD 
couples who were offered to participate in the study, 69% of the mothers took 
part and 77% of all participants completed all three questionnaires until the 
child was one year old. The response rate of the OD fathers was 75%. 
A noteworthy strength of studies III and IV was that the whole cohort of 
mothers and fathers who had a child after gamete treatment after treatment 
in 1991-2007 were asked to participate. In study III, the response rate among 
mothers (68%) and fathers (61%) was high and similar for parents with 
different ages of children. The data provided information on 164 OD children 
which is one of the largest known follow-up studies on these children. In 
previous studies, the participation rate has been low or parents have actively 
been willing to be contacted for research purposes (Klock and Greenfeld, 
2004; Shehab et al., 2008; Applegarth et al., 2016). 
For study IV, the questionnaire was sent to 252 heterosexual couples, 
separately to mothers and fathers, who had become parents with donor 
insemination or donor IVF treatment. Information was received on 58% 
(240/415) of children born to these couples. In previous studies, disclosure 
intentions have been examined among heterogenous groups of parents, 
except for heterosexual couples, also single mothers and lesbian couples. 
Absence of a father in the family requires an explanation to the child and 
thus disclosure rates are expected to be higher (Scheib et al., 2003). In 
addition, most of previous studies have examined parental disclosure 
intentions after DI treatment but not separately after donor IVF treatment 
where not only male factor infertility exists but a female factor as well. 
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One limitation of the studies I and II are the low number of patients 
Matching was considered to be successful. Because of lack of controls at 
similar age we had to allow four controls from a lower age group of mothers. 
However, the mean age of mothers was statistically similar between the 
groups (Studies I–II). 
Unfortunately, no information is available for patients who declined 
participation in the studies (I–IV). Parents declining to answer questions in 
studies III and IV are most likely in favour of secrecy (Nachtigall et al., 1997; 
Gottlieb et al., 2000; Klock and Greenfield, 2004). 
Generally, questionnaire studies have some limitations that warrant 
mention. Self-reported data is suitable to assess subjective well-being but 
reporting somatic symptoms during pregnancy may differ from medical 
records. This apply to questions about children’s health which were answered 
by parents and not confirmed from medical records. A child’s health problem 
may have an impact on parents’ willingness to inform the child about the way 
of the conception. 
Mental health problems, fear of childbirth, and pregnancy-related anxiety 
were instead reported with validated questionnaire tools such as GHQ-36, 
FDQ, and PAS. Self-reported mental health symptoms are potentially 
vulnerable to social desirability among couples undergoing OD and IVF/ICSI 
(Holter et al., 2006). 
 
 
7.1. FEAR OF CHILDBIRTH AND DELIVERY 
EXPERIENCE OF OD MOTHERS 
 
Women pregnant after successful OD were hypothesised to be more likely to 
suffer from fear of childbirth and pregnancy-related anxiety due to their 
demanding background and process achieving pregnancy. 
Instead, this study showed that women pregnant with donated oocytes 
experienced less fear of childbirth and pregnancy related anxiety than 
IVF/ICSI and SC controls. The majority of OD women in this study had POI 
for which OD is the only available treatment option and they became 
pregnant on average after two ET cycles. Except for the reasons of infertility, 
background measures for infertility such as duration of infertility/wish for 
pregnancy and number of previous failed treatments were similar in OD and 
IVF/ICSI groups and thus do not explain the lower level of fear of childbirth. 
One reason for mother’s fear of childbirth is often the fear of unknown, 
especially for primiparas. Couples have faced the feeling of unknown when 
they accepted an anonymous donor chosen for them and accepted the fact 
that the child is not genetically their own. For young women with POI, the 
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possibility to deliver by using donated oocytes might be seen to be an 
immensely positive option and gift, as they had no gametes themselves. One 
can speculate that this opportunity is a way to deliver against “all odds”, and 
might alleviate feelings of fear. Nowadays, most OD treatments are 
performed on women aged over 40 years, who usually have previously 
undergone several unsuccessful conventional IVF treatments. Whether the 
fear of childbirth in this group of patients is comparable to that of POI 
women cannot be concluded from this study. 
OD pregnancies are associated with adverse maternal and neonatal 
outcomes. OD mothers were well informed about these risks before 
pregnancy even started and that their pregnancy would be followed in a 
hospital outpatient clinic which may have decreased their concern about 
child’s health and anxiety of pregnancy. Hospitalisation due to pregnancy 
complications was more common among OD mothers than IVF/ICSI and SC 
mothers, which was expected. The reasons for hospitalisation were not 
closely analysed or they were hospitalised with milder symptoms than 
IVF/ICSI and SC mothers. OD mothers taking part in this study had fewer 
adverse pregnancy outcomes. This finding may be due to the fact that they 
were relatively young for OD mothers and risks in OD pregnancies partly 
associate with advanced maternal age. 
Before the treatment started, all couples met a mental health professional 
at least once and had several meetings with medical personnel to discuss 
their well-being, parenthood, their future thoughts, and concerns about their 
child. Support, which OD mothers received during the treatment and during 
the pregnancy, may have alleviated their fear. Interestingly, OD women were 
the most confident receiving help and support from the hospital personnel 
during the pregnancy and delivery. Confidence towards medical personnel 
can result in satisfaction of care in the fertility clinic. OD women also felt the 
most confident about the health of their future child. This may be explained 
by the fact that the oocyte was received from young, healthy women. 
Supportive partnership is reported to reduce mother’s fear of childbirth 
(Saisto et al., 1999; Laursen et al., 2008). OD couples represent a specific 
group whose partnership is strong enough to withstand the stress of 
infertility. This study may be criticised for not including satisfaction with 
partnership in the analyses. However, the fertility treatment with donated 
oocytes is generally postponed or withdrawn by the mental health 
professionals if any problems in partnership occur until they have been 
resolved. 
Including depression and general anxiety into the analysis would have 
been important because these are risk factors for increasing fear of 
childbirth. However, all couples were screened for mental health symptoms 
by mental health professionals before treatment. 
Pregnancy-related anxiety and fear of delivery are at their lowest during 
the second trimester (Rouhe et al., 2008) when the measurement of FDQ 
and PAS were done. Formerly infertile women may idealise their pregnancy 
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and fail to prepare for the realities of giving birth in the second trimester 
(Hammarberg et al., 2008). Therefore, fear of delivery should have been 
measured again during the third trimester. 
Research on the delivery experience of formerly infertile women is 
conflicting. Feeling out of control, separation from the baby, and 
postoperative pain have been associated with negative experience 
(Hammarberg et al., 2008) leading to difficulties in feeding the infant and 
anxiety about infant care (Rowe-Murray et al., 2001; Waldenström et al., 
2004; Fisher et al., 2012). Very few OD women were dissatisfied with their 
delivery, which was reassuring. Interestingly, acute operative deliveries 
were associated with dissatisfaction only in OD mothers, contrary to what 
has been reported earlier among all mothers. Fear of delivery and 
intolerable pain was associated with dissatisfaction in all women, which is 
in line with previous studies (Waldenström et al., 2006; Söderquist et al., 
2009; Flykt et al., 2014). 
Delivery complications may deepen the sense of failure in being unable to 
become a mother naturally. Surprisingly, the way of delivery was similar 
between the groups which made the results naturally more reliable. 
Caesarean rate was high in all groups and higher than in Finland generally 
(National Institute of Health and Welfare Statistics, 6/2018). According to a 
systematic review of OD pregnancies, caesarean rate has been twice as high 
in OD pregnancies than in IVF/ICSI and SC pregnancies (Storgaard et al., 
2016). The reasons for caesareans were not analysed, which was a limitation 
of the study. One reason for elective caesarean may be fear of childbirth but 
also several other reasons. Elective caesarean rate was the highest (23%) 
among OD mothers who feared childbirth less compared with IVF/ICSI and 
SC mothers whose elective caesarean rates were 20% and 14% respectively. 
The results suggest that OD mothers are not at greater risk for fear of 
childbirth or negative delivery experience, however, acute operative 
deliveries were associated with delivery dissatisfaction among OD women. 
Therefore, health care personnel should focus on supporting these women in 
early parenthood. Because pregnancy risks in OD pregnancies are higher, 
multiple pregnancies should be avoided by transferring only one embryo and 
thus alleviating maternal anxiety of fetal well-being and decreasing risks for 
operative delivery. 
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7.2. MENTAL HEALTH OF OD PARENTS 
 
Mental health problems of one or both parents have an impact on the well-
being of the whole family (Blake et al. 2014), parent-child relationship, and 
parental marital relationship during and after fertility treatment. Typically, 
OD families have been excluded from previous studies. 
OD mothers were hypothesised to report higher levels of mental health 
problems during pregnancy and early parenthood due to their more 
problematic reproductive background. For fathers, no hypothesis was 
provided due to lack of studies. 
Contrary to the hypothesis, OD women showed lower levels of mental 
health symptoms during pregnancy and postpartum than IVF/ICSI women 
and SC women. Differences were statistically significant at 2 months and one 
year postpartum, but not during pregnancy. 
No statistically significant group differences were found in depressive 
symptoms across the transition to parenthood. This is a reassuring finding 
because maternal depression may be a risk for infant-mother relationship 
and interfere fetal attachement (Seimyr et al., 2009; Field, 2011; Dix et al., 
2014). It would have been a merit to add the Edinburgh Postnatal 
Depression Scale (EPDS) questionnaire to screen and detect postnatal 
depression among mothers. 
Child-related stressors are associated with mental health problems among 
infertile parents (Lynch et al., 2014). A longer stay in the hospital after the 
delivery or hospitalisation in pregnancy are usually related to health 
problems among mothers or fetus and newborn. When the results were 
covariated with hospitalisation in the 2nd and 3rd trimester, and with 
hospitalisation length postpartum, OD mothers demonstrated better stress 
tolerance than IVF/ICSI and SC mothers. This may be because OD mothers 
were better prepared for higher risks for perinatal complications and when 
they finally had gotten their highly desired child and resolved the infertility 
trauma, they had created better coping skills. In addition, mothers with a 
tendency for distress had dropped out before entering OD treatment. Finding 
that infertile couples cope well with different stressors has been confirmed in 
earlier studies (Repokari et al., 2005; Poikkeus et al., 2006). This study 
sample size was too small to permit close examination of the impact of child-
related stressors on mental health of OD parents, but it should be examined 
in the future with a larger study population. 
The reasons for the current results indicating that OD mothers had fewer 
mental health symptoms than IVF/ICSI and SC mothers may lie in their 
proper preparation for parenthood. At the time of the study, the waiting time 
for treatment was 1-2 years due to a shortage of donors. Couples had a 
chance to adapt to parenthood and obtain information about treatment and 
pregnancy risks. Counselling was available to offer discussions about the 
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feelings of infertility, future parenthood and child. However, counselling was 
available for IVF/ICSI patients as well, but it was not similarily included in 
the treatment process as it was in the OD donation program. Well-being of 
mothers may also reflect their satisfaction with an almost unreal dream of 
getting pregnant. 
Supportive partnership may have helped both partners in their transition 
to parenthood. Marital satisfaction was not included in the analyses, which is 
a limitation for the study. Duration of partnership did not differ between the 
groups, mean 5 years, but duration does not reflect the quality of the 
partnership. Couples suffering from any kind of psychological distress might 
have been more likely to abandon the treatment with donated oocytes as well 
as support and treatment for their problems, thereby causing selection bias. 
The expected results for fathers with an OD child were uncertain 
compared with IVF/ICSI and SC fathers, due to limited research data. In this 
study, the mental health of men becoming fathers through OD appeared 
similar to that of the IVF/ICSI and SC groups at all three time-points. These 
results are in accordance with some previous studies reporting that anxiety 
and depression symptoms were similar among IVF/ICSI and SC fathers 
(McMahon et al., 2002; Gibson et al., 2007). 
 
 
7.3. INCREASING OPENNESS OF PARENTS IN OOCYTE 
DONATION FAMILIES 
 
The purpose of this study was to gather information of parental decision- 
making regarding OD treatment itself, disclosure to the child and to other 
people, and level of satisfaction up to 15 years after the treatment. 
The results revealed that 26% of all children aged 3–14 had already been 
told about his/her origin and in addition 36% of the mothers and 38% of the 
fathers had decided to inform the child later. Parents with younger children 
(aged 1–3) were more likely to inform the child than parents with older 
children (aged 10–14). These findings are in line with other studies (Gottlieb 
et al., 2000; Lalos et al., 2007; Daniels et al., 2009; Isaksson et al., 2011). 
According to a review article on parents’ disclosure intentions, 0–51 % had 
told their child (aged 0–15) about the conception with donated oocytes and 
over 50% intended to do so (Tallandini et al., 2016). In 1998, fewer parents of 
this same cohort intended to inform their child about his/her origin and as 
many as 30% had decided never to inform the child (Söderström-Anttila et 
al., 1998). This is one of the few known studies reporting parental intentions 
at two time points, 13 years apart. 
Change in parental intentions may have two explanations. In 1998, children 
were still too young to be told and/or attitudes of the parents have changed 
towards more openness during these years. Reasons for changed attitudes 
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towards more openness have been seen in changes of views towards gamete 
donation in general, as OD has become a more accepted method to treat 
infertility. Change in public attitudes toward more openness led Finland also 
to pass an ART Law to allow only open-identity gamete donors. At the same 
time, the role of mental health professionals in all kinds of ART treatments 
were more acknowledged (Benward, 2015). As general attitudes changed, 
professionals started to more actively encourage the parents towards 
openness as family secrets were considered harmful for the whole family 
(Indekeu et al., 2013). 
At the time of the study, the majority of donors were anonymous but 15% 
of couples had decided to use a known donor. This had no effect on parental 
disclosure decisions. Furthermore, indication for treatment, socioeconomic 
status, marital relationship, or difficulties in decision making regarding OD 
treatment did not influence parental disclosure intentions. Those who had 
told or intended to do so, did it because they felt it was fair and because the 
child had the right to know. On the other hand, those who did not plan to tell 
the child thought that the information is unnecessary or that it could harm the 
child. Non-disclosers were also more influenced by other people’s opinions. 
The majority of the parents had told the nature of their child’s conception to 
other people, mothers more often than fathers. This can be seen as a signal 
towards greater openness. However, many had not told the child yet, so they 
were ready to take the risk for accidental disclosure. Half of the parents 
reported thought that they will inform the child to spare him/her from 
accidental disclosure, which can be a traumatic experience for the child. 
One of the very positive findings of this study was that a great majority of 
parents had maintained their marital relationship despite infertility 
problems and long waiting time for fertility treatment. This result has been 
confirmed by Repokari et al. (2007), when they showed that shared stress 
may strengthen the marital relationship. Furthermore, it was also reassuring 
that 90% of the parents reported that the decision to start the treatment with 
donated oocytes was easy and that they had very few concerns about the 
characteristics of the anonymous donor. All parents wrote that they felt that 
the child was really their own. 
The fact that almost half of the parents felt that psychological support had 
been insufficient requires attention. The parents wished they would have had a 
chance to discuss with the counselor immediately after the delivery and at the 
time to inform the child to receive guidance regarding when and how to tell. 
This criticism should be taken seriously and encourage parents to seek support 
after the child is born. At that point, professionals could learn more about the 
parents’ feelings after successful treatment to be able to better inform future 
parents-to-be and alleviate their fear of the unknown. Continuity of support 
for the parents and the children have become of utmost importance today in 
Finland, with an open-identity donor system and possibility for donor 
offspring to have contact with the donor some day in the future. 
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This study only included parents who were treated before the ART law came 
into act in 2007. Parental opinions about the new law were sought, and only 
one third of mothers and one quarter of fathers favoured requirements for 
open-identity donation. Nevertheless, 40% of the parents reported that the 
law would not impact on future parents’ disclosure intentions. 
 
 
7.4. ATTITUDES AND DISCLOSURE DECISIONS OF 
DI/DIVF PARENTS 
 
This study involved the collection of information on parental disclosure 
intentions regarding 240 children born after DI/dIVF treatment during a 
15-year period. 
The main finding was that 16.5% of parents had told their child about 
their donor conception. This is in line with earlier studies, which have 
reported that 11–35% of parents have told (Gottlieb et al., 2000; Lycett et al., 
2005; Isaksson et al., 2012; Frith et al., 2018). The highest percentages (93%) 
have been reported among single mother and lesbian couples (Scheib et al., 
2003). Oocyte donation parents generally show greater openness than sperm 
donation parents (van den Akker, 2006). This was also found in this study as 
26% of OD children had received information on the donor conception. 
Differences related between sperm and oocyte donation may be 
explained by the fact that a woman is related to her child genetically but 
also through gestation, but a man only genetically through his sperm 
(Isaksson et al., 2011). In addition, men are in general less likely to talk 
about the infertility problem they face (Hjelmstedt et al., 1999). A genetic 
tie with the child seems to be very important for men (Ravin et al., 1997). 
Those men who need donated sperm cells are more secretive than women 
who need donated oocytes (Isaksson et al., 2011). Almost 19% of parents 
had disagreement with their disclosure decision and there is evidence that 
when parents disagree or are unsure, they later choose not to tell (Daniels 
et al., 2009). This study examined whether parental disclosure decisions 
were different if there was also a female infertility factor present and hence 
partners were equally involved in their infertility problem. It lacked any 
separate effect on the decision. 
Parents with younger children were more willing to tell the child about 
his/her conception. This is most likely a result of counselling which 
increasingly started to emphasise the importance of being honest. In the 
1980s and 1990s, secrecy was recommended by some professionals. At the 
beginning of the study period counselling was not mandatory as it is today. 
The results showed that parents whose child was born before 2000 were 
more often unsatisfied with the psychological support they received 
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compared with parents after 2000. This finding may partly explain parental 
disclosure decisions and why so many were left unsure with their decision to 
disclose or not. In line with the OD parents, the parents with donor sperm 
offspring reported a great need for support, not only before the treatment but 
when the child was born and when it was time to tell. Rumball and Adair 
(1999) reported a need for ongoing support for parents after gamete 
donation treatment as well. 
About half of the parents had informed other people about the donor 
conception. Fathers were more secretive compared with mothers, when 
nearly 50% of them had not told anyone about the donor conception. Higher 
tendency for secrecy among fathers has been reported before (Isaksson et al., 
2011). Of those who had told other people, very few regretted. Some parents 
commented though that they should not have told the medical personnel 
about the donor treatment because these persons had talked about the donor 
conception when the child was present. Contrary to an OD pregnancy, 
DI/dIVF pregnancy is not considered to be high-risk. Oocyte donation 
mothers are thus advised to inform medical personnel and this risk explains 
why OD mothers inform medical personnel more often than DI/dIVF 
conceived mothers (82% vs. 50%). 
It is a reassuring finding that parental satisfaction about the treatment 
decision was high. About 20% of parents answered that the decision to start 
the treatment with donated sperm cells was difficult and sadly two mothers 
reported regretting the treatment. All parents felt that the child was their 
very own. They had very few concerns about the characteristics of the donor, 
which can be interpreted as a confidence in the donor screening program. In 
this study, only 15% of parents were divorced and similar results have been 
reported earlier except for one study where 46% of couples had separated 
(Daniels et al., 2009). A high rate of separation may be a result of insufficient 
psychological support for these couples. 
This study was conducted at the time when donors were anonymous and it 
must be kept in mind that the results might be different today. All couples had 
received treatment in only one fertility clinic in Helsinki. Clinics vary in their 
clinical practices and thus the results should be interpreted with caution. 
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8. SUMMARY AND CONCLUSIONS 
“Infertility touches all aspects of a person’s life. It affects how individuals feel 
about themselves, their relationships, and their life perspective. Stress is only 
one of a myriad of emotional realities that couples facing infertility deal with, 
often for extended periods of time”, Hart (2002) described very well what 
couples face when the infertility problem is present. 
Our results are encouraging. OD mothers showed less fear of childbirth 
and pregnancy-related anxiety than their IVF/ICSI and naturally conceived 
controls. This study was the first to examine fear of childbirth among OD 
mothers and their experience of delivery. Higher levels of fear of childbirth 
and pregnancy-related anxiety were expected because of their previous 
problematic reproductive background. However, the OD mothers’ experience 
of childbirth was similar to that of IVF/ICSI and SC mothers. 
Fear and/or anxiety during pregnancy and dissatisfaction with delivery 
may affect maternal attachment with the fetus and most importantly mother-
infant relationship, especially when there is no genetic connection between 
mother and the infant. One might conclude that low levels of mental health 
problems among OD mothers are partly reflecting lower levels of fear of 
childbirth and pregnancy-related anxiety, as well as support they received 
from the fertility clinic, maternity health care, and hospital outpatent clinics. 
In contrast with the main hypothesis, parental mental well-being was 
similar or better than IVF/ICSI and spontaneously conceiving parents. 
Pretreatment preparation may have helped OD mothers and fathers to cope 
with the distress they face. Unfortunately, parental well-being when there are 
child-related stressors present could not be examined. OD couples consist of 
a selected group of infertile women and men and it can cause bias to the 
results. They were screened for mental health symptoms and problems in 
their marital relationship and received treatment and support before being 
allowed to start the treatment. Couples who are unable to withstand stress 
are more likely to drop out earlier and not even consider starting treatment 
with donor gametes. 
Secrecy is inevitably the most challenging issue that parents face when 
they have a child conceived with donated gametes. These studies showed that 
parental openness towards the child had increased during the years. The 
same tendency was seen both among parents who had a child with sperm 
donation and among parents whose child was born with donated oocytes. As 
expected, based on earlier reports, sperm donation parents were more 
secretive than OD parents. Those who had decided to tell the child about the 
donor conception had told or intended to tell because they want to be open 
and honest and the child has the right to know. Those parents who had 
decided not to tell were afraid that the information would do harm for the 
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child. In addition, some parents felt that telling is unnecessary when they 
cannot provide any further information on the anonymous donor. 
Parents were given a chance to discuss with mental health professionals 
about the issues of secrecy. Parents’ opinions were sought about the support 
they received. Both sperm donation parents and OD parents reported 
dissatisfaction because they had needed ongoing support when the child was 
born and when it was time to disclose. This criticism should be taken 
seriously and clinics should encourage families to make contact with mental 
health professionals as well as peer support groups whenever they needed. 
On the other hand, OD mothers’ pretreatment support may have helped 
them to cope with pregnancy-related stress. Yet, issues regarding disclosure 
are either so complicated or the quality of counselling did not meet this 
purpose. 
Since these studies were conducted, much has changed in the field of 
donor ART. General attitudes towards gamete donations have changed 
towards openness leading many countries including Finland to change their 
legislation. Today, all donors in Finland are open-identity donors and the 
offspring have a right to obtain identifying information of the donor at the 
age of 18. Change of legislation may have influenced parental disclosure 
intentions and should be examined in the future. 
Legislation varies in many countries leading to the rise of cross-border 
donation treatments. Worries have increased whether these couples 
travelling abroad receive counselling in their home country in their own 
language or do they enter the treatment without this guidance. Secrecy issues 
concerning gamete donation can be very different in different cultural and 
social environments. 
Until now, the use of anonymous donors has not allowed donor-conceived 
offspring to find out their genetic parent. International genetic databases and 
genetic testing make it possible for a donor conceived offspring to find their 
genetic relatives. Genetic testing may uncover secrets about one’s donor 
conception. Furthermore, gamete donors who choose nonidentifiable 
donation have to be informed that their anonymity is not guaranteed. It is 
impossible to say yet how genetic testing is going to impact on parental 
disclosure decisions, or does it have an impact on recruiting donors. 
Finally, when a couple comes and requests treatment with donated gametes, 
decision to proceed or not should always be in the best interest of the future 
child. Research will reveal what is the best interest of the child by asking 
donor-conceived children about their experiences. Mahlstedt and Greenfeld 
wrote wisely in 1989 about the need for patient preparation: “To most 
couples wanting to have children, conception is the first step toward the 
fulfillment of that goal. To the infertile couple who has been through years of 
emotional turmoil and physical pain, conception is the goal and represents 
the end of very grueling process. To specialists in reproductive medicine, 
conception means success of treatment. To the hoped-for children, however, 
conception is the beginning of their lives.” 
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APPENDIX 
Table 9. Fear of Delivery Questionnaire (FDQ) 
Each question to be answered yes = 1 or no = 0. 
Score being the sum of the answers. 
1. Do you have difficulties relaxing because you are thinking of 
the delivery? 
2. Do you prefer a caesarean section to an ordinary delivery? 
3. Are you afraid of rupturing during the delivery? 
4. Have you had nightmares about the delivery? 
5. Have you sometimes thought of dieing during the delivery? 
6. Are you afraid of losing control of yourself at the delivery? 
7. Are you afraid of painful injections during the delivery? 
8. Have you always been afraid of giving birth? 
9. Are you afraid of being seized with panic at the delivery? 
10. Are you afraid of being left alone? 
11. Are you afraid of unhealthy child? 
 
Table 10. Pregnancy Anxiety Scale (PAS) 
Answers on five-point scale: 1 = not at all, 2 = a little, 3 = some,  
4 = yes, 5 = a lot 
Score being the sum of the answers. 
1. Has anyone frightened you about having a baby? 
2. Have you read anything that frightened you about having a baby? 
3. Do you fear that you would fall and hurt your baby? 
4. Are you afraid the pain of childbirth would be bad? 
5. Are you going to ask for pain medicine in delivery? 
6. Do you fear about being cut when the baby is born? 
7. Are you afraid your baby would not be normal? 
8. Are you afraid you would be alone in the hospital? 
9. Are you worried that the doctors might not be friendly? 
10. Are you worried that the nurses might not be friendly? 
 
Table 11. Delivery Satisfaction Scale (DSS) 
Answers on five-point scale: 1 = not at all, 2 = a little, 3 = some,  
4 = yes, 5 = a lot 
Score being the sum of the answers. 
1. Was the delivery a positive experience? 
2. Did you receive sufficient support from the obstetric ward personnel? 
3. Did you receive sufficient support from your partner? 
4. Was the labor painful? 
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5. Did you receive efficient pain relief during labor? 
6. Did you feel safe during the labor? 
7. Did you have enough influence on the treatment you received 
during labor? 
8. Did the obstetric ward personnel patronise you too much 
during labor? 
 
 
